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Public health laboratories face considerable challenges to ensuring performance of critically 
important testing services. These challenges stem from financial constraints and uncertainties, 
ever more sophisticated electronic systems, and new demands on laboratory professionals, 
among other factors. The Centers for Disease Control and Prevention and the Association of 
Public Health Laboratories cosponsor the Laboratory Efficiencies Initiative to help public 
health laboratories ensure long-term sustainability by exploring and adopting measures that can 
improve their efficiency and cost-efficiency. Interstate test service sharing is one of the most 
promising strategies toward that goal.
This Policy Guide is a resource that public health laboratory directors and their colleagues can 
use as they explore legal and other policy questions related to state public health laboratories’ 
sharing test services with each other. The guide is primarily based on information that 17 
state public health laboratory directors and their colleagues voluntarily provided about their 
experiences with addressing such questions.
Key Findings
• Of the sample of 17 public health laboratory directors interviewed, 13 reported 
participating in a total of 18 formal test service sharing agreements they had initiated. 
(Fifteen other state laboratories participated in those agreements with them.)
• Nine of the agreements were for emergency-related testing; seven were for newborn 
screening testing; and two were for disease-specific testing.
• All the emergency-related agreements were in the form of memoranda of understanding 
(MOUs); the other agreements were a mix of MOUs and contracts.
• All 17 laboratories also participated in test service sharing projects that CDC had initiated 
and sponsored.
Two legal concerns were identified as the most problematic for development of formal test 
service sharing agreements —
• liability: the potential that a state laboratory might be held legally liable for another state 
laboratory’s actions or omissions to act; and
• exchange of funds: mechanisms for payment by one state laboratory to and receipt of 
payment from another laboratory for tests performed.
This Policy Guide presents practical information that laboratory directors might find helpful 
as they explore ways to address these and other questions. Among the resources included are a 
checklist and self-assessment template. The Policy Guide also includes a list of actual test service 
sharing MOUs and contracts that exemplify how individual public health laboratories have 
addressed such concerns. As appropriate, these can be used as templates for development of new 
test service sharing agreements in other states.
SUMMARY
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1. INTRODUCTION
1.1 The Policy Guide’s Purpose
This Policy Guide is a resource that public health laboratory directors and their colleagues can 
use to explore legal and other policy considerations related to state public health laboratories’ 
sharing of test services with each other. The guide is primarily based on real-world experiences 
that state public health laboratory directors have had with such challenges, centering 
predominantly on testing that involves human specimens. As described in Section 1, a total of 
17 directors participated in research for the guide. They generously volunteered information 
and lessons learned from their experiences as well as examples of relevant laws and other legal 
resources.
Many public health laboratories have experience in conducting tests for each other, often on an 
informal basis, in at least one of the following contexts:
• On an occasional basis when special expertise or testing resources might be needed that 
a public health laboratory temporarily lacks. Such testing typically involves low-volume 
testing.
• Routinely when one laboratory determines that another laboratory is better suited to 
perform a particular type of test on its behalf on a continuing basis.
• In emergency settings when the volume of tests exceeds a laboratory’s capacity (e.g., as 
happened during the 2001 anthrax response and the 2009 influenza A [H1N1] pandemic) or 
when a temporary interruption in operations requires calling on another laboratory for surge 
capacity.
• In programs and projects sponsored by the Centers for Disease Control and Prevention 
(CDC) (e.g., the vaccine-preventable disease [VPD] reference laboratory project that CDC 
initiated in 2012). The participating laboratories have developed formal service sharing 
agreements for some, but not all, of these projects.
In addition to informal arrangements, certain state public health laboratories have developed 
formal agreements through which they perform specified tests for each other. Many laboratory 
directors are interested in exploring the potential benefits of expanding test service sharing. An 
important part of that exploration is identifying laws and other types of policies that support or, 
alternatively, constrain test service sharing.
This Policy Guide includes helpful resources for the reader interested in pursuing test service 
sharing agreements with another state.
• Resource 1 is a checklist for assessing and testing service sharing laws and legal 
considerations.
• Resource 2 is a self-assessment of laws and policies pertinent to interstate test service 
sharing agreements.
• Resource 3 lists selected test service sharing agreements contributed by participating 
laboratory directors; the full agreements are available on the APHL website for members.
• Resource 4 includes example provisions of service sharing agreements.
• Resource 5 is a bibliography of information sources.
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1.2	 The	Public	Health	Laboratory	Efficiencies	Initiative
Additional impetus for test service sharing has come from financial and workforce constraints 
that have affected public health laboratories in recent years and from challenges posed by new 
testing platforms and the rapidly evolving health care sector. These and other factors place a 
premium on maximizing laboratories’ operating efficiency.
CDC and the Association of Public Health Laboratories (APHL) inaugurated the Laboratory 
Efficiencies Initiative (LEI) in early 2011 to help address these concerns. LEI’s mission is to 
help public health laboratories ensure their long-term sustainability through adoption of practices 
that can improve their operational and cost efficiencies. One of the LEI strategic goals is to 
ensure that individual public health laboratories and the public health system as a whole have the 
capacity needed to address health threats. Additional information about the LEI is available at 
http://www.aphl.org/lei.
1.3 Background
On August 17, 2012, the five state public health laboratory directors who composed APHL’s 
standing Legislation and Policy Committee met in Atlanta, Georgia, to discuss policies related to 
interstate test service sharing. They were joined by representatives from APHL and several CDC 
programs.
Although the discussion considered federal policies, it focused primarily on state laws and 
policies ranging from statutes and regulations that expressly govern laboratory practices to 
privacy laws and agencies’ policies related to financial, procurement, and other administrative 
matters. Examples were provided of laws and other policies that are supportive of test service 
sharing and examples of others that can constrain it. Committee members noted that, in certain 
cases, what laboratory directors believe are relevant laws might reflect perceptions rather than 
actual laws and policies.
The committee noted that information is limited regarding implications that laws and other 
policies have for test service sharing. The committee requested that APHL and CDC develop 
a practical resource that public health laboratory directors can use to better understand such 
concerns and to assess the pertinent laws and policies of their own states. This Policy Guide is 
that resource.
As used in this Policy Guide, key terms are defined as follows:
•	 Public health laboratory includes all state, local, environmental, agricultural, and food 
laboratories and laboratories that engage in testing for the health of the population.
•	 Test service sharing is the performance by one state public health laboratory of testing on 
behalf of another state public health laboratory.
•	 Law refers to statutes adopted by state legislatures and regulations adopted by state 
executive-branch agencies.
•	 Other policies refers to state policies that are subordinate to statutes and regulations (e.g., 
procurement policies adopted by centralized state administrative agencies or universities).
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1.4	 Methods	Used	to	Develop	the	Policy Guide
Researchers with the nonprofit Institute for Community Health (ICH) located in Cambridge, 
Massachusetts, compiled information for the guide through interviews with the directors, 
senior staff, and legal counsel of 17 state public health laboratories who offered to participate 
in the research. Their work was funded by the Public Health Law Research Program at Temple 
University (Philadelphia, Pennsylvania) with support from the Robert Wood Johnson Foundation 
(Princeton, New Jersey). The research plan and protocols were reviewed and approved by 
ICH’s institutional review board, and the interviews were conducted during April–July 2013. In 
parallel, the CDC Public Health Law Program reviewed and analyzed pertinent state and federal 
laws.
The following topics were suggested for the respondents’ consideration, but they were invited to 
address other topics as well:
• authority to participate in test service sharing,
• payment for shared test services,
• risk management,
• privacy protection,
• certification and licensure,
• specimen management and use,
• disease reporting, and
• emergency management.
Information derived from interviews and legal research was supplemented with information 
that APHL and CDC staff received from state public health laboratory directors through routine 
channels (e.g., LEI teleconferences and meetings) and one-on-one interaction with public health 
laboratory directors and their senior staff. Because the available resources precluded gathering 
information from all states’ laboratories, APHL polled its members to identify those interested 
in participating. Thirty-two (64%) of the state laboratory directors responded. The sample of 17 
states was selected to represent state laboratories that had experience with test service sharing. 
(Local public health laboratories participated in the poll but were not included in the research 
because those responding to the poll reported limited experience with test service sharing.)
The public health laboratories that participated in this research serve Alabama, Arizona, 
California, Connecticut, Florida, Idaho, Illinois, Iowa, Kansas, Montana, New Hampshire, New 
Mexico, New York, Texas, Washington, Wisconsin, and Wyoming. The majority conduct a wide 
range of infectious disease testing as well as environmental testing. Fourteen perform genetic 
testing as part of their state’s newborn screening (NBS) programs.
The 17 states include a mix of populous states with multiple metropolitan areas and sparsely 
populated, primarily rural states. With one exception (the Mid-Atlantic region), the states 
represent all U.S. regions and account for 50.8% of the total population (as of July 1, 2012). 
Fifteen of the laboratories are units of their states’ public health departments, and two are integral 
parts of state public universities.
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The laboratory directors were the researchers’ points of contact and had the option of inviting 
staff to participate in interviews. Eleven state interviews were with the laboratory director alone. 
From two to seven state staff participated in the six other state interviews. Nine counsel in four 
states participated. In all, 41 persons were interviewed.
With permission of the laboratory directors, the ICH researchers recorded the interviews and 
returned verbatim transcripts to the directors for their review and emendation. The directors 
were assured that, aside from themselves and others they might authorize, only the research team 
would have access to the transcripts. All respondents were assured anonymity, if they wanted, 
and were given an opportunity to review and comment on a draft of the Policy Guide before its 
publication.
The CDC Public Health Law Program conducted online research regarding the laws of the 17 
states pertinent to their public health laboratories’ participation in interstate test service sharing. 
This research included analysis of specific laws the state respondents mentioned as relevant to 
test service sharing. Legal researchers also reviewed relevant federal laws.
1.5 Limitations and Disclaimer
The 17 laboratories are not necessarily representative of all state laboratories or of local public 
health laboratories. Enlarging the sample size undoubtedly would have allowed capture of 
additional, and perhaps different, information. Also, ICH researchers conducted interviews with 
a limited number of representatives from each participating laboratory. The research findings 
reported in this Policy Guide stem from their recall and extensive experience but might not 
reflect all the legal and related policy questions their laboratories have encountered in the context 
of test service sharing.
Although this Policy Guide reports on the views and information shared by public health 
laboratory directors and other state employees, the researchers, analysts, and writers who 
prepared it bear responsibility for any inaccuracies. Information in this guide does not constitute 
legal advice and does not represent the views of CDC or of the U.S. Department of Health and 
Human Services. Moreover, this guide is not intended as a substitute for professional legal or 
other advice.
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2. KEY FINDINGS
The following summary of key findings is based on information that participating state 
public health laboratory directors and their colleagues shared with Policy Guide researchers, 
supplemented by information received from other public health laboratory professionals and 
from APHL and CDC programs.
2.1	 Participation	in	Interstate	Test	Service	Sharing
State public health laboratories frequently share test services with the laboratories of other states 
on an informal basis. Such testing typically responds to ad-hoc, short-term needs and involves a 
limited volume of tests.
Of the 17 state laboratories that participated in the Policy Guide research, 13 reported 
participating in 18 formal test service sharing agreements that they had initiated. Additionally, 
all 17 laboratories participated in one or more test service sharing programs or projects that CDC 
initiated. These projects range from the 50-state Laboratory Response Network (LRN) that began 
in 1999 to smaller-scale pilot projects initiated more recently and of limited duration.
2.2 Formal Agreement Vehicles
The directors reported using memoranda of understanding (MOUs) and contracts as the vehicles 
for the majority of the formal agreements initiated. Two laboratories reported using their states’ 
Emergency Management Assistance Compact (EMAC) legislation as the initial vehicle for a 
NBS testing arrangement after Hurricane Katrina occurred in 2005. They later converted it to a 
contract. The MOUs and contracts shared with researchers indicated that states have addressed 
liability and payment questions in both types of vehicles.
Whether to use an MOU or contract or to rely on informal agreements is influenced by the 
perceptions held by the laboratory directors, state health officials, their legal counsel, and others 
regarding the laboratory’s mission, the likelihood of exposure to liability claims, procurement 
laws, and other considerations. Selected contracts and MOUs provided by the participating 
laboratory directors are listed in Resource 3 of this guide; the full text of the agreements are 
available to APHL members in the APHL Members Resource Center.
2.3	 Reported	Legal	Barriers	to	Test	Service	Sharing
The participating laboratory directors identified two legal considerations that have caused the 
most difficulty for their initiation of formal test service sharing agreements not related to CDC-
funded testing arrangements —
• the potential that one state laboratory might be held legally liable for another state 
laboratory’s actions or omissions to act; and
• payment by one state laboratory to another or receipt of payment for tests performed.
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Directors also mentioned they had encountered legal questions related to privacy protection, 
laboratory accreditation, and employee certification and licensure when exploring development 
of test service sharing agreements. However, they indicated those had been less problematic than 
liability and payment questions. None of the states reported encountering serious legal concerns 
in the CDC-sponsored test service sharing projects.
2.4	 Concerns	Regarding	Test	Service	Sharing
The majority of the 17 directors anticipated increasing their laboratories’ participation in test 
service sharing in the future but expressed concern regarding such problems as
• The often lengthy and difficult process of negotiating formal agreements with officials in 
their own state and with those of other states;
• for a laboratory that requests testing services by another laboratory, the potential that it 
might lose capacity to perform high-priority tests and have difficulty in rebuilding that 
capacity if it were needed in the future;
• the possibility that the laboratory performing tests might give a requesting laboratory’s 
tests lower priority, especially when the testing laboratory is in the midst of responding to a 
public health emergency in its own state; and
• the potential for reductions in a laboratory’s funding and staff positions if participation in 
test service sharing is regarded as inappropriate outsourcing of testing to another state.
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3. FORMAL TEST SERVICE SHARING ARRANGEMENTS
This section describes the interstate test service sharing arrangements that were instituted as 
of mid-2013 in the 17 participating states. It also summarizes test service sharing projects that 
CDC has initiated. Comparison of the two helps illuminate factors that can facilitate or impede 
formation of test service sharing across state lines. This section also describes selected principal 
reasons state laboratories and CDC programs have reported for forming such arrangements as 
well as factors considered as they were explored and shaped.
3.1	 Overview	of	Formal	Agreements	Initiated	by	State	Public	Health	
Laboratories
Of the 17 laboratories that contributed to the Policy Guide research, 13 reported that as of mid-
2013, they were participating in 18 total formal interstate test service sharing agreements they 
had initiated. However, additional agreements might have been in place that were not identified 
by the research.
• Two participated in two agreements (each with one other state laboratory) for disease-
specific testing services.
• Seven participated in nine agreements for emergency-related testing.
• Nine participated in seven agreements for NBS testing.
Of the 18 formal agreements,
• six used contracts as the vehicle, and
• 12 used MOUs as the vehicle, including two termed management agreement or partnership 
agreement, both hereafter referred to as MOUs.
Table 1 summarizes these arrangements and indicates that the vehicles for test service sharing 
included MOUs and contracts.
Table	1.	State-Initiated	Test	Service	Sharing	Agreements	in	Effect	as	of	
Participating 
States Services	Provided Vehicle
Payment 
for	Services Liability
A. Disease-specific	testing
South	Carolina	and	
Alabama
Alabama’s PHL performs 
tuberculosis microbial-
resistance	testing	for	
South	Carolina’s	PHL	
for	five	primary	drug	
susceptibilities
Contract
South	Carolina	
reimburses 
Alabama for 
agreed-upon	
fees
Each state is 
responsible	for	
its	own	actions	
and	omissions
Mid-20131,2
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Participating 
States Services	Provided Vehicle
Payment 
for	Services Liability
Florida	and	
Louisiana
Florida’s	PHL	performs	
confirmatory	tests	for	
preliminary	positive	point-
of-care	HIV	rapid	test	
results
MOU
Louisiana	
reimburses 
Florida	for	
agreed-upon	
fees
Each state is 
responsible	for	
its	own	actions	
and	omissions
B. Emergency-related testing
New	Mexico,	
Colorado,	Utah,	
and	Arizona	(the	
Four	Corners	area)
Each	PHL	performs	clinical	
and	environmental	tests	
for the other PHLs “to 
maintain	their	continuity	
of	operations	[if	they	are]	
temporarily	unable	to	
perform	such	testing”
MOU
Each PHL 
reimburses the 
other	according	
to	its	own	fee	
schedule
Each state is 
responsible	for	
its	own	actions	
and	omissions
Alaska,	Idaho,	
Oregon,	and	
Washington	(the	
Cooperative	of	
State	Laboratories)
Any	PHL	may	request	
surge	support	for	routine	
disease	outbreak	and	
bioterrorism	testing,	and	
other	relevant	services
MOU
The	requesting	
PHL replaces 
supplies the 
testing	PHL	
uses
Each state is 
responsible	for	
its	own	actions	
and	omissions
Alaska,	Idaho,	
Oregon,	
Washington,	British	
Columbia,	and	the	
Yukon	Territory	(the	
Pacific	Northwest	
Emergency	
Management	
Arrangement)
Any	member	may	request	
emergency	assistance	
from other members 
(not	limited	to	laboratory	
services)
Management	
agreement	
with	
implementing	
state 
legislation3
The	requesting	
state must 
reimburse the 
assisting	state	if	
requested
The	requesting	
state assumes 
liability for the 
testing	state
Mississippi	and	
Alabama
Each PHL may perform 
clinical	and	environmental	
tests for the other PHL 
during	“a	severe	disruption	
of	analytical	services	or	an	
emergency”
MOU
“No 
compensation	
will	be	paid	or	
requested”
Not	addressed
Tennessee	and	
Alabama
Each PHL may perform 
clinical	and	environmental	
testing	for	the	other	PHL	
during	“a	severe	disruption	
of	analytical	services	or	an	
emergency”
MOU
“No 
compensation	
will	be	paid	or	
requested”
Not	addressed
Washington	and	
California
Each PHL agrees to 
perform	testing	for	the	
other	PHL	related	to	
chemical terrorism or 
large-scale chemical 
incidents
MOU Not	addressed
Each state is 
responsible	for	
its	own	actions	
and	omissions
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Participating 
States Services	Provided Vehicle
Payment 
for	Services Liability
Idaho	and	Alaska
Idaho	and	Alaska	
“agree to cooperate 
and	share	laboratory	
services,	procedures,	
responsibilities	and	
reimbursement	for   
testing,	training,	and	
identification	of	drinking	
water	contaminants”
Partnership	
agreement3
The	requesting	
PHL replaces 
supplies the 
testing	PHL	
uses
Each state is 
responsible	for	
its	own	actions	
and	omissions
Montana	and	Idaho
Each PHL agrees to 
perform	surge	viral	testing	
for	the	other	PHL	during	
emergencies
MOU
The	testing	PHL	
bills	according	
to	its	own	fee	
schedule
Not	addressed
Montana	and	North	
Dakota
North Dakota’s PHL 
may perform molecular 
testing	(for	influenza	A	or	
B,	norovirus,	pertussis,	
herpes	simplex	virus,	
varicella	zoster	virus,	
and	Enterovirus)	during	
disasters
MOU
North Dakota 
bills	for	testing	
services	
according	to	
its	own	fee	
schedule
Not	addressed
C. NBS testing
Alaska,	Hawaii,	
Idaho,	Nevada,	and	
New	Mexico
Oregon’s	PHL	performs	
tests	on	a	routine	basis	
for other states’ NBS 
programs	as	well	as	its	
own
Contracts	
between	
Oregon’s	
PHL	and	
other 
states’ NBS 
programs
Oregon	bills	the	
other states’ 
NBS programs 
and	health	care	
providers
Not	determined
Maine,	New	
Hampshire,	
Rhode	Island,	and	
Vermont
The	University	of	
Massachusetts performs 
tests	for	Maine,	New	
Hampshire,	Rhode	Island,	
and	Vermont	as	well	as	for	
Massachusetts
Contracts
The 
University	of	
Massachusetts 
bills the states’ 
health	and	
human	services	
agencies	for	
actual costs4
The	contractor	
indemnifies	
the	requesting	
state	and	holds	
it harmless for 
the	contractor’s	
actions	and	
omissions4
Florida	and	Texas
Florida’s	and	Texas’	PHLs	
perform tests for each 
other	during	disasters	and	
catastrophic	technology	
failures
MOU 
between	
the NBS 
programs
The	requesting	
NBS program 
reimburses the 
costs	of	testing
Each state is 
responsible	for	
its	own	actions	
and	omissions
. . . 
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Participating 
States Services	Provided Vehicle
Payment 
for	Services Liability
North	Dakota	and	
Iowa
Iowa’s	PHL	performs	tests	
for the North Dakota health 
department
Contract
Iowa	bills	North	
Dakota for 
specified	fees
Iowa	
indemnifies	
North Dakota 
for claims 
related	to	
Iowa’s	actions
South	Dakota	and	
Iowa
Iowa’s	PHL	performs	tests	
for South Dakota Contract
Iowa	bills	South	
Dakota health 
care	providers	
and	birthing	
centers
Iowa	assumes	
negligence-
related	liability
Montana	and	
Wisconsin
Wisconsin’s	PHL	performs	
tests	for	Montana’s	PHL MOU
Wisconsin	bills	
Montana’s	PHL	
according	to	
Wisconsin’s	fee	
schedule
Not	addressed
Colorado	and	
Wyoming
Colorado’s	PHL	performs	
tests	for	Wyoming’s	NBS	
program
Contract
Not	determined	
by research 
for this Policy 
Guide
Not	determined	
by research 
for this Policy 
Guide
Abbreviations:	HIV,	human	immunodeficiency	virus;	MOU,	memorandum	of	understanding;	NBS,	newborn	
screening;	and	PHL,	public	health	laboratory.
1	 A	list	of	selected	MOUs	and	contracts	referenced	in	this	table	is	included	in	Resource	3,	and	the	contracts	and	
MOUs	are	online	at	the	Association	of	Public	Health	Laboratories	members	resource	center.
2	 Reported	by	the	17	state	public	health	laboratories	that	participated	in	the	Policy Guide research.
3	 Considered	MOUs	for	the	purposes	of	this	Policy Guide.
4	 Provisions	of	the	New	Hampshire	contract.
3.2	 Test	Service	Sharing	Vehicles
This section describes the contracts and MOUs that laboratory directors who participated 
in the Policy Guide research reported using for formal test service sharing agreements. This 
section also reviews legal and other policy questions the directors encountered as they explored 
and developed those arrangements. Supplemental information is included based on related 
communications that APHL and CDC had with other public health laboratories.
States have inherent authority to enter into contracts and typically delegate that authority to 
executive-branch agencies. Of the 17 states represented, at least seven appear to delegate 
contracting authority to their state health departments.
Certain conventional distinctions between contracts and MOUs are that contracts define the 
parties’ responsibilities in more detail, contain greater specificity (about such factors as payment, 
liability, and conformity with standards), and can be enforced through court proceedings, 
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arbitration, or other means. A standard legal reference, for example, states “A contract is a 
promise or set of promises for the breach of which the law gives a remedy, or the performance of 
which the law in some way recognizes as a duty.”1 
Three elements typically are required to make a contract a binding agreement: an offer — one 
party proposes to provide a service to the other party; acceptance — the receiving party accepts 
the offer; and consideration — the receiving party agrees to pay for the service.
In contrast, MOUs often are thought to articulate and document parties’ general roles in 
a collaborative venture and not to involve payment between the parties or to be legally 
enforceable. These conceptual distinctions, however, can be less clear in practice than in legal 
theory. Some test service sharing MOUs referenced in Table 1 underscore this point because they 
contain specific provisions regarding liability, indemnification, payment, and compliance with 
federal and state privacy laws. One even specifies the state whose laws will govern any dispute 
between the parties.
Public health laboratories’ legal counsel best understand how the laws of their states apply to 
contracts and MOUs for test service sharing.
3.2.1 Contracts
Five of the 17 participating state laboratories reported successfully entering into a total of six test 
service sharing contracts.
• Alabama and South Carolina developed a contract through which the Alabama laboratory 
performs tuberculosis antimicrobial susceptibility testing for South Carolina. This 
arrangement started as an MOU and was converted to a contract a year later. The contract 
negotiations reportedly were uncomplicated, in part because of the successful track record 
under the MOU. Liability provisions, among other details, had been resolved in the MOU. 
In addition, the states’ counsels were credited with understanding the importance of 
continuing the testing program.
• Five contracts were for NBS test services. In these cases, a state public health laboratory 
that agrees to perform NBS tests might contract with its counterpart laboratory in the other 
state or with that state’s NBS program. Three states with small populations chose to have 
another state’s public health laboratory perform their NBS testing. Costs might be further 
elevated when new types of tests are mandated that involve expensive new technologies. 
Small-population states also might opt to have NBS tests performed in another state if they 
lack the expertise needed to perform clinical follow-up steps based on NBS test results.
• Three of the NBS agreements involve broad test panels: the Oregon state public laboratory 
conducts NBS testing for Alaska, Idaho, Nevada, and New Mexico; Colorado tests for 
Wyoming; and Iowa tests for North Dakota and South Dakota. During emergencies, Florida 
and Texas are authorized to conduct tests for each other. The focus is narrower in one of the 
five agreements: Wisconsin performs tandem mass-spectrometry tests for Montana.
1 Restatement (Second) of Contracts, Section 30. The American Law Institute, 1981.
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3.2.2 MOUs
The state laboratory directors who contributed to the Policy Guide research reported entering 
into 12 test service sharing MOUs. A total of 22 states participated in those MOUs.
Disease-Specific Testing
During 2012, the Miami regional public health laboratory, part of the state public health 
laboratory, entered into an MOU with the Louisiana public health laboratory to perform Food 
and Drug Administration (FDA)-approved human immunodeficiency virus (HIV)-1 Western 
blot confirmatory tests for presumptive positive point-of-care HIV test results. Florida statutes 
authorize interstate test service sharing only in the event of an emergency. In this context, Florida 
counsel deemed the fact that the Louisiana laboratory cannot perform this test as constituting 
an emergency. The agreement specifies payment by Louisiana and, for purposes of liability, 
specifies that each state is responsible only for its own actions and omissions to act.
Emergency-Related Test Service Sharing
Seven of the directors interviewed reported using a total of nine MOUs as vehicles for 
emergency-related test service sharing. In this context emergency is variously defined as 
including large-scale disasters and public health emergencies, unforeseen disruption of a 
laboratory’s operations by flooding or other external event, and interruption of testing services 
(e.g., when a laboratory temporarily closes for planned maintenance or cleaning). The majority 
of the nine MOUs do not provide for reimbursement to the testing laboratory. Moreover, in 
the majority of the MOUs, the parties agree to be legally responsible only for their own acts or 
failures to act; some MOUs do not address liability.
• Arizona, Colorado, New Mexico, and Utah executed the Four Corners MOU in 2009 and 
renewed it in 2013. Under this agreement, each laboratory may request testing assistance 
from the others in a broad set of emergency-related circumstances. Members agree to 
reimburse each other for testing services they provide. The agreement specifies that the 
states are not liable for each other’s actions.
• Dating from 1996, the Pacific Northwest Emergency Management Agreement (PNEMA) 
among five U.S. states and two Canadian provinces is in the general form of an MOU. It 
authorizes broad provision of mutual assistance by all relevant state/provincial agencies, 
including state public health laboratories. Oregon and possibly other states enacted 
legislation to further specify activities under PNEMA. Members agree to reimburse for 
services rendered if requested. The jurisdiction that requests assistance assumes liability.
• Four Pacific Northwest state laboratories executed the Cooperative of State Labs 
agreement in 2004 specifically to provide “surge capacity for routine disease outbreaks and 
bioterrorism events.” Each laboratory agrees to replenish supplies the assisting laboratory 
uses on its behalf; each laboratory assumes liability only for its own actions and omissions 
to act.
• Alabama’s public health laboratory has MOUs with Mississippi and Tennessee authorizing 
all three to perform clinical and environmental testing services when one of the other 
laboratories’ operations are disrupted or during emergencies. These MOUs do not address 
reimbursement and liability.
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• California and Washington executed an MOU in 2005 for mutual aid in the event of 
biochemical terrorism. It provides for replenishment of supplies and specifies that each 
state is responsible for its own actions.
• The Montana state public health laboratory has two emergency-related MOUs in place. 
The MOU with Idaho refers to emergencies in broad terms. The MOU with North Dakota 
provides for the North Dakota laboratory to perform molecular testing for Montana for 
different infectious diseases during disasters when results are needed urgently for patient 
decisions or outbreak investigations. Neither MOU addresses liability, but both provide for 
reimbursement.
• The Policy Guide researchers learned of other test service sharing agreements that did not 
involve the 17 states. In one MOU, for example, a state public health laboratory agrees to 
perform variola virus confirmatory testing for the public health laboratory of a neighboring 
state in response to a “real or perceived terrorist attack.” That MOU does not address 
payment or liability questions. (Both laboratories requested anonymity.)
NBS Testing
Four states reported using MOUs as the vehicle for agreements to perform NBS testing.
• An MOU between the Florida and Texas state NBS programs commits their respective 
state laboratories to performing NBS testing for each other when needed in the context of 
disasters and “catastrophic technology failures.” The requesting NBS program is expected 
to reimburse the costs of testing. Each state agrees to be responsible for any liability 
associated with its actions or failures to act.
• The Wisconsin state public health laboratory entered into an MOU to perform NBS tests 
for the Montana state NBS program. The Wisconsin laboratory bills Montana’s health 
department for specified costs.
3.2.3	 Negotiating	Provisions	of	Contracts	and	MOUs
The participating laboratory directors mentioned two unsuccessful attempts to develop MOUs 
that would have supported testing surge capacity during emergency situations. One, the former 
Mid America Alliance initiated in 2004, failed to reach agreement over specific legal provisions, 
reportedly centering on liability concerns. At least one of the states that participated in those 
negotiations ultimately engaged a private laboratory to assist in surge testing. The other attempt 
was to develop surge capacity for environmental testing but was not finalized, at least in part 
because of disagreements over indemnification and accreditation of the member laboratories by 
the National Environmental Accreditation Conference.
The laboratory directors indicated considerable variation in their state partners’ understanding 
of parameters on the use of MOUs. One director said that her state’s MOUs are legally binding. 
Another indicated that MOUs are a traditional vehicle that is sanctioned by the office that 
handles contracts. Other states indicated they use MOUs specifically as a legally accepted 
alternative to the cumbersome processes their states are required to use when developing and 
executing contracts.
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The majority of the identified MOUs provide for payment by one state to another. Some include 
elements more typical of contracts (e.g., provisions related to liability and privacy protection). 
Directors noted that certain elements have proven difficult to resolve while proposing and 
negotiating MOUs.
3.2.4 Comparing Vehicles
Contracts and MOUs
Table 1 reveals apparent distinctions among the states’ use of contracts and MOUs as vehicles 
for formal test service sharing.
• Two of the seven NBS test service sharing agreements were in the form of contracts.
• All but one of the other agreements were MOUs; the exception is the five-year contract 
between the Alabama and South Carolina public health laboratories for tuberculosis 
microbial resistance testing.
Overall, contracts appear to have been used for test service sharing arrangements that have the 
following characteristics:
• an expected volume of tests that are performed on a frequent and routine basis, as is the 
case with NBS testing;
• a well-defined set of markers or conditions for which testing is performed;
• an established array of tests and test methods that adhere to widely accepted quality 
standards (e.g., standards of the Newborn Screening Quality Assurance Program) and thus 
help allay concerns regarding liability; and
• an institutionalized source of funding (e.g., health insurance plans) and established billing 
systems.
In contrast, MOUs appear to have been used in test service sharing arrangements with the 
following general characteristics:
• unpredictable volumes of tests that are performed infrequently, for which advance warning 
is limited or nonexistent, or that might have potential to overwhelm the testing capacity of 
a laboratory;
• tests that might be for novel (e.g., influenza A [H1N1]) or especially dangerous biologic, 
chemical, or radiologic pathogens and toxins; and
• no established, uniform source or mechanism for payment.
Aside from their use in NBS testing agreements, the laboratory directors reported that contracts 
were their least-favored vehicle for test service sharing because of
• the complex procedural aspects of complying with states’ procurement regulations, 
especially if a proposed contract is subject to competitive bidding and award; (Several of 
the laboratory directors reported that fulfilling mandatory procedural requirements could 
take months, and one director reported that it had taken 3 years to execute an interstate test 
service sharing contract.)
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• states’ often disparate contract requirements that might require extended negotiations 
between their respective legal counsels; and
• concerns regarding the participating states’ liability if they fail to fulfill the procedural 
requirements of a contract or if a patient or community alleges that the laboratory did not 
exercise responsible judgment in conducting tests and reporting test results.
Laboratory directors cited multiple attempts to develop test service sharing contracts that 
ultimately were not concluded. Differences in states’ requirements related to protection against 
liability claims were reported to have been a frequent point of disagreement.
Despite such challenges, some laboratory directors reported that their states prefer, or require, 
contracts as the vehicles for test service sharing, especially when one state pays another state. 
Other directors reported a preference for MOUs because they might be easier to negotiate and 
more readily modified, if necessary, as laboratories gain experience implementing test service 
sharing.
Informal Agreements
Some laboratory directors reported preferring ad-hoc or director-to-director agreements to formal 
agreements but understood that they might not be entirely risk-free. These agreements exemplify 
the practical, mission-driven ethos typical of public health practitioners; tend to be grounded in 
preexisting, professional relationships among laboratory directors; and to a certain extent, reflect 
states’ geographic proximity.
Two directors determined that making informal arrangements for test service sharing for 
chemical terrorism was easier than establishing an MOU for that purpose. The problem in that 
case was less one of legal impediments than the perception that elected officials might object 
to one laboratory’s taking on additional workload when the decision had been made earlier to 
reduce state funding for that laboratory.
Informal test service sharing appears to be practiced by laboratories whose leaders meet 
regularly to explore opportunities for collaboration in multiple areas. Some regional consortia 
of state laboratories have completed inventories of their testing capabilities so that each state 
laboratory can know which of the others might be able to perform a rare or low-volume test for 
which it lacks the needed capacity.
The Northern Plains Consortium arrangement is the longest existing of these consortia. The 
state laboratories that serve Montana, North Dakota, South Dakota, and Wyoming began 
collaborating in 1999; the Idaho laboratory joined the consortium in 2013. A modest CDC grant 
in 2005 assisted the consortium in strengthening the region’s clinical laboratories’ antimicrobial 
sensitivity testing abilities. Thereafter, the state laboratories, using their own resources, have 
performed designated testing services for each other that are low in volume but entail high 
cost for laboratories that have to maintain capacity to perform those tests. Some of the shared 
testing services are for the HIV multispot test, 16s ribosomal bacterial identification, hantavirus 
serology, certain IgM serologies, and pulsed-field gel electrophoresis for nonenteric pathogens. 
Payment between the laboratories, which is infrequent, is by invoice and is based on the testing 
18	 Policy	Guide
Formal	Test	Service	Sharing	Arrangements
laboratory’s fee schedule. The consortium state laboratories also collaborate in workforce 
development, communication planning, specimen exchange, electronic laboratory data exchange, 
and reducing procurement costs.
3.3	 Test	Service	Sharing	Sponsored	by	CDC
As of mid-2013, CDC programs sponsored and funded eight systems or projects in which 
state public health laboratories performed tests for each other for designated purposes. Some 
participating public health laboratories also exchanged other services with each other (e.g., 
training and technical consultation).
Four of these projects supported national networks whose members included all or the majority 
of state public health laboratories, multiple county or city public health laboratories, and CDC 
laboratories. Other federal laboratories also participate in the Laboratory Response Network-
Biological (LRN-B) and the Laboratory Response Network-Chemical (LRN-C). The following 
networks have been in continuous operation since they were established:
• PulseNet was established in 1996 to detect and facilitate investigation of foodborne 
bacterial outbreaks by using pulsed-field gel electrophoresis to accurately subtype 
pathogens.
• CaliciNet was initiated in 2009 to improve detection of norovirus outbreaks.
• The LRN-B was created in 1999 to improve detection of biologic threats associated with 
terrorism. CDC requires each LRN-B laboratory, as part of a biennial requalification 
process, to affirm that, “As a member of the network and as state and local resources and 
priorities permit, our laboratory agrees to support surge capacity testing associated with 
testing exigencies, especially during a declared national emergency.”
• Also in 1999, the LRN-C was established to improve detection of biologic and chemical 
threats associated with acts of terrorism. CDC requires all Level 3 LRN-C laboratories to 
establish MOUs with LRN-C laboratories in other jurisdictions.
Each of these networks has tiers of laboratories with progressively greater analytic capacity. In 
the LRN-B, for example, suspect biologic samples that cannot be accurately typed by a sentinel 
laboratory can be referred to approximately 160 reference laboratories (the majority of them 
public health laboratories) that have greater analytic capacity and, if necessary, can be referred 
further to CDC and other federal laboratories for definitive analysis.
The following four CDC-sponsored projects were smaller-scale reference-center pilots with 
lifespans of only 2–5 years, extending into 2013. These projects made highly specialized testing 
and related laboratory methods available to public health laboratories that lack that capability, 
to assess the feasibility of concentrating certain testing services in selected state public health 
laboratories, and for other reasons.
• The Influenza Resistance Testing project was established to ensure that three sophisticated 
types of antimicrobial resistance testing are available to all states, including states that 
lack that capacity. As of mid-2013, New York’s state public health laboratory performed 
pyrosequencing resistance testing for 15-20 public health laboratories lacking that capacity 
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(and for certain public health laboratories with it). Three state public health laboratories 
(California, Utah, and Washington) performed virus isolation testing and neuraminidase 
inhibition testing for all other states.
• In the HIV NAT Referral Project, the Florida and New York state public health laboratories 
performed nucleic acid testing (NAT) for 29 submitting public health laboratories.
• During a tuberculosis project, the Colorado state public health laboratory performed first-
line drug susceptibility testing (DST) for the Montana, North Dakota, South Dakota, Utah, 
and Wyoming state laboratories and for Denver’s public health laboratory. The California 
state public health laboratory performed pyrosequencing to detect resistance-associated 
mutations and DST for Wisconsin.
• Through the Vaccine-Preventable Disease Reference Laboratories project, the California, 
Minnesota, New York, and Wisconsin state public health laboratories provided testing 
for measles, mumps, rubella, varicella-zoster virus, rotavirus, pertussis, Haemophilus 
influenzae, Neisseria meningitidis, and Streptococcus pneumoniae for 30 state and nine 
county public health laboratories.
During these projects, the laboratories performing testing services also provided other 
laboratories with assay protocols, education, and other services. Table 2 indicates the purpose of 
each of the CDC-sponsored projects, the services provided, and the public health laboratories that 
participated in them as of mid-2013.
Table	2.	CDC-Sponsored	Test	Service	Sharing	Projects	in	Effect	as	of	Mid-2013
Project Purpose and Participation1 Services	Provided
PulseNet
•	 Improve	detection	of	
foodborne	disease	
outbreaks;	87	state	
and	local	PHLs,	state	
agricultural,	and	federal	
food	regulatory	agency	
laboratories participate
•	 8	regional	or	area	PHLs	provide	surge	capacity	for	
subtyping	(e.g.,	pulsed-field	gel	electrophoresis)	for	
member	PHLs	(e.g.,	during	widespread	outbreaks	
and	laboratory	staffing	shortages)
•	 8	regional	PHLs	also	provide	training	and	
troubleshooting	for	PHLs	in	their	areas
CaliciNet
•	 Improve	detection	of	
norovirus	outbreaks;	28	
state	PHLs	and	4	local	
PHLs participate
•	 32	PHLs	perform	real-time	polymerase	chain	reaction	
testing	to	detect	norovirus	in	outbreak	samples	and	
conduct	sequencing-based	subtyping
•	 Five	outbreak	support	centers	provide	norovirus	
sequencing	for	PHLs	lacking	that	capacity
LRN-B
•	 Improve	preparedness	
and	response	to	biologic	
public	health	threats;	all	
state PHLs participate
•	 Private,	commercial,	and	public	clinical	laboratories	
refer	suspicious	samples	to	~160	reference	
laboratories	(state	and	local	PHLs	and	others)
•	 National	laboratories	(CDC,	the	US	Army	Medical	
Research	Institute	for	Infectious	Diseases,	and	the	
Naval	Medical	Research	Center)	perform	the	highest-
level	tests
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Project Purpose and Participation1 Services	Provided
LRN-C
•	 Improve	response	to	
chemical public health 
threats;	all	state	PHLs	
and	the	PHLs	of	the	
District	of	Columbia,	Los	
Angeles	County,	New	
York	City,	and	Puerto	Rico	
participate
•	 54	Level	3	laboratories	assist	hospitals,	and	first	
responders	identify	and	coordinate	response	to	
chemical	exposure	incidents
•	 36	Level	2	laboratories	identify	and	coordinate	
response	to	chemical	exposures	and	test	to	detect	
exposure	to	multiple	toxic	chemicals
•	 46	Level	1	laboratories	identify	and	coordinate	
response	to	chemical	exposure	incidents	and	test	to	
detect	exposure	and	act	as	surge	capacity	for	CDC
Influenza	
Resistance	
Testing
•	 Assist	identification	of	
resistant	influenza	strains
•	 Perform	tests	for	PHLs	
lacking	testing	capacity
•	 Provide	surge	capacity	for	
CDC
•	 The	New	York	PHL	performs	pyrosequencing	
resistance	testing	for	PHLs	lacking	that	ability	(and	
for	some	of	the	20	PHLs	that	have	it)	and	for	CDC	for	
surge purposes
•	 The	California,	Utah	and	Wisconsin	PHLs	
(“contract	laboratories”)	perform	virus	isolation	and	
neuraminidase	inhibition	testing	for	all	other	state	
PHLs
•	 The	California,	Utah	and	Wisconsin	PHLs	send	viral	
isolates	to	CDC	for	further	characterization	and	for	
use	in	vaccine	strain	selection
Vaccine	
Preventable	
Disease 
Reference	
Laboratories
•	 Determine	if	turnaround	
time is acceptable for 
broader	implementation
•	 Provide	viral	molecular	
and	bacterial	assays	to	
reference	laboratories	not	
available	commercially
•	 Harmonize	assays	for	
interpretation	consistency	
and	simplify	proficiency
•	 The	California,	Minnesota,	New	York,	and	Wisconsin	
state	PHLs	test	measles,	mumps,	rubella,	varicella-
zoster	virus,	rotavirus,	pertussis,	and	Haemophilus 
influenzae,	Neisseria meningitidis,	and	Streptococcus 
pneumoniae	for	30	state	and	nine	county	PHLs
•	 Sequencing	and	genotyping	is	provided	for	viral	
vaccine-preventable	diseases,	except	rotavirus
•	Wisconsin	develops	and	provides	proficiency	testing	
panels	for	Bordetella	species,	N. meningitidis,	and	
H. influenzae	for	all	state	PHLs	not	performing	such	
tests
Tuberculosis 
Testing
•	 Explore	alternative	
service	delivery	models	
and	evaluate	potential	
cost	savings	and	impact	
on	quality	of	service	
delivery
•	 Rapid	direct	detection	by	NAA	testing
•	 Iowa	performs	NAA	tests	for	Missouri
•	 DST
—	 California	performs	pyrosequencing	to	
detect	resistance-associated	mutations	and	
conventional	DST	for	Wisconsin
—	 Colorado	performs	first-line	DST	for	Denver,	
Montana,	North	Dakota,	South	Dakota,	Utah,	and	
Wyoming
—	 New	York	performs	DST	for	Rhode	Island
•	 NAA	testing
—	 Montana	performs	NAA	testing	for	Wyoming
—	 Montana,	North	Dakota,	and	Wyoming	
conducted	combined	educational	campaign	with	
tuberculosis	program	managers	and	infectious	
disease	physicians
HIV NAT 
Referral 
Project
•	 Perform	NAT	testing	for	
PHLs	with	cost-inefficient	
testing	volume
•	 Florida	and	New	York	provide	NAT	for	29	submitting	
sites
Abbreviations:	DST,	drug	susceptibility	testing;	HIV,	human	immunodeficiency	virus;	LRN-B,	Laboratory	Response	
Network-Biological;	LRN-C,	Laboratory	Response	Network-Chemical;	NAA,	nucleic	acid	amplification;	NAT,	nucleic	
acid	testing;	and	PHL,	public	health	laboratory.
1	 See	also	the	services	provided	column	for	additional	participation	information.
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No legal or other policy concerns that might have impeded public health laboratories’ 
participation in the projects were reported in five of the eight projects. Potentially problematic 
legal questions reported for the three other projects were related to laboratories’ receipt of 
payment from other states for testing services they provide to those states, state procurement 
law and payment for testing services, and licensure for laboratory professional staff. As noted 
in more detail in Section 4, these questions were resolved successfully, and the concerned state 
laboratories were able to participate in the projects with minimal hindrance.
3.4	 Why	Public	Health	Laboratories	Participate	in	Test	Service	Sharing
The public health laboratory directors who participated cited four principal reasons for initiating 
test service sharing, separate from sharing initiated by CDC. The reasons, which varied from 
state to state, included the following:
• The high cost of performing and maintaining capacity to perform certain low-volume tests.  
Laboratory directors serving large but sparsely populated states cited the challenge of 
maintaining testing capacity for rare or unusual diseases (e.g., botulism, hantavirus, and 
certain VPDs). The related costs include establishing the testing apparatus, training and 
maintaining the skills of the staff who perform the tests, and meeting quality-control and 
proficiency testing requirements.
• The high cost of developing capacity to perform new assays or tests for novel diseases and 
conditions.  
Approximately one-half of the interviewed directors cited the challenges associated with 
developing capacity to perform newer tests (e.g., influenza A [H1N1] during the pandemic 
of 2009, genetic tests added to newborn screening panels, and whole genome sequencing). 
Although all directors expressed interest in developing such capacity, they recognized 
that not all laboratories can afford the new equipment and expertise such tests require. 
Relatedly, two states also cited the challenges that state procurement laws and procedures 
can pose when new testing platforms must be acquired.
• Emergency response and continuity of operations planning.  
Many of the directors said that strengthening their laboratories’ ability to respond to public 
health and other emergencies was a major impetus to developing test service sharing 
arrangements with other states’ laboratories. The majority of the directors had experience 
managing laboratories during epidemics, natural disasters, and major disruptions of their 
laboratories’ work. All of the directors considered that their laboratories’ highest priorities 
include protecting the public from major threats and that providing for surge testing 
capacity through test service sharing is crucial for fulfilling that role.
• Fulfillment of mission to serve the public.  
Underlying all the other reasons for initiating test service sharing is the state public health 
laboratory directors’ commitment to fulfilling their laboratories’ overriding mission 
of protecting the public’s health. The APHL publication The Core Functions of State 
Public Health Laboratories defines functional elements needed to support that mission.2 
2 Association of Public Health Laboratories. The Core Functions of State Public Health Laboratories. Silver Spring, MD: APHL; 
2010. Available at: http://www.aphl.org/aboutaphl/publications/documents/com_2010_corefunctionsphls.pdf.
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The interviewed laboratory directors explicitly discussed the potential that test service 
sharing can help fulfill that mission, especially given the deep budget and staff cuts their 
laboratories have experienced during the economic recession and the directors’ expectation 
that substantial new resources are unlikely to materialize.
Laboratory directors cited these and additional benefits to participating in test service sharing 
activities that CDC sponsors, such as the following:
• the ability for requesting laboratories to have tests performed that might exceed their 
technical capacity, especially testing that involves new or expensive methods and 
platforms;
• the ability all the participating laboratories have to obtain test results on high-priority 
disease concerns for the populations they serve; and
• the opportunity such arrangements offer for the laboratories that perform tests to build and 
strengthen their technical and scientific capacity.
CDC’s purposes in the projects in which all state public health laboratories participate — 
PulseNet, CaliciNet, LRN-B, and LRN-C — are to improve nationwide detection of foodborne 
disease outbreaks and preparedness and response to biologic and chemical threats and to 
terrorism. They signify the federal government’s recognition that states lack the capacity and 
mandate to ensure that the nation’s public health laboratory system can address those health 
priorities adequately. CDC provides funding to the participating laboratories and, in certain 
instances, also provides reagents, training, and technical consultation.
A common goal for the other projects CDC sponsors is to determine whether a limited number 
of adequately resourced public health laboratories can perform tests — against defined criteria 
— for states that lack the necessary testing capacity. Criteria for evaluating success include 
turnaround time (24 hours in the case of the VPD project) and other service-quality indicators. 
An additional purpose of the LRN-C and Influenza Resistance Testing projects is to perform tests 
for CDC when the volume of testing needed exceeds CDC’s capacity.
3.5	 Selected	Concerns	Regarding	Test	Service	Sharing
Laboratory directors’ appreciation of the potential benefits of test service sharing was tempered 
by perceived risks. Key concerns expressed included the following:
• Potential loss of in-house testing capacity.  
Directors noted that relying on another state’s laboratory can result in loss of professional 
staff, expertise, and equipment and render their laboratories unable to perform critically 
important tests if needed in the future. A laboratory that divests itself of vital institutional 
knowledge and capacity might not have a credible backup plan if the laboratory that 
performs tests on its behalf finds it cannot continue that service.
• Potential loss of control over high-priority testing.  
Public health laboratory directors who are considering having another laboratory perform 
tests on their behalf are concerned that that laboratory might feel compelled — especially 
in the context of an anthrax attack such as that of 2001 or a multistate epidemic — to place 
first priority on completing its own state tests.
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• Potential impediments to supporting the mission of the state’s public health agency.  
Interviewed directors reported they would be happy to perform tests for another state 
laboratory if the needed agreements could be arranged. In contrast, they also acknowledged 
that they are reluctant to give up testing capabilities, particularly for routine and high-
visibility tests. They consider that service to their states’ own population, programs, and 
other stakeholders to be their laboratories’ defining mission, and that relinquishing testing 
to another state’s laboratory has potential for reducing their laboratory’s ability to fulfill 
that mission.
• Potential loss of support among elected officials.   
States’ public health leaders ultimately are accountable to executive and legislative 
officials. Laboratory directors appreciate the importance of maintaining those officials’ 
support for the laboratory and do not want participation in test service sharing to result 
in misperceptions about the laboratory. Agreeing to perform tests for another state 
laboratory or to have another laboratory do tests might result in questions, for example, 
about the laboratory’s level of funding, its use of state resources, and its responsiveness 
to state needs, or conversely, the possibility of transferring additional testing services 
to other public or private entities. The interviewed laboratory directors underscored the 
importance of engaging state health officials, state epidemiologists, and state public health 
program leaders who rely on laboratory test results during any exploration of potential test 
service sharing. All these partners have standing expectations for laboratory services that 
support their decision making and program operations. They might have concerns that the 
laboratory’s potential participation in test service sharing will affect their access to essential 
test results and related information.
Despite these reservations, the directors acknowledged the benefits of working collaboratively 
across states to maintain testing services, especially during emergencies. They also 
acknowledged that the likely persistence of budget constraints will require more creative 
thinking regarding ways to ensure continuity of existing testing services.
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4. REVIEW OF LAWS AND LEGAL CONSIDERATIONS
The state public health laboratory directors and colleagues who participated in the Policy Guide 
research were asked in interviews to identify and comment on laws, legal questions, and other 
policy challenges they have found to be supportive of or impediments to test service sharing. 
The following eight topics were suggested for their consideration (the directors were invited to 
discuss additional topics as well):
• authority to participate in test service sharing,
• payment for shared test services,
• risk management,
• privacy protection,
• certification and licensure,
• specimen management and use,
• disease reporting, and
• emergency management.
Section 4 reports on the information that directors and their colleagues provided during those 
interviews and includes supplemental information, as appropriate.
Briefly, the principal findings were as follows:
• None of the 17 states appears to have laws that expressly authorize or prohibit test service 
sharing.
• With only one exception, the absence of such authority does not appear to have precluded 
development of formal test service sharing agreements.
• Concerns that stem from state laws associated with liability and payment for test services 
have complicated states’ initiation of formal test service sharing agreements.
• Other laws and legal mandates are relevant to test service sharing and might warrant 
attention by public health laboratory directors who want to explore developing formal test 
service sharing agreements.
4.1	 Authority	to	Participate	in	Test	Service	Sharing
A threshold question is whether public health laboratories have legal authority to engage in test 
service sharing. Legal authority that supports public agency actions can take different forms, 
including legislatively enacted statutory provisions that expressly permit, or even require, 
specified actions and administrative regulations or rules. In certain cases, the absence of an 
express legal prohibition might be construed as condoning given activities. The majority of 
states have enacted laws that establish public health laboratories, or their parent public health 
departments, and that authorize promulgation of rules and regulations regarding the laboratories’ 
activities.
The 17 participating directors (and their legal counsel) indicated that none of their states’ laws 
expressly authorize the laboratories’ entering into formal agreements for test service sharing. 
In contrast, the majority believed that the statutes that authorize and enable the laboratories or 
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their parent agencies confer sufficient authority to do so. For example, enabling statutes might 
require the public health laboratory or its parent agency to perform tests important to the public’s 
health or to ensure that such tests are performed. Some directors interpreted such provisions as 
authority to share test services with other state laboratories if, in their professional judgment, 
doing so would help fulfill that responsibility (e.g., because a laboratory lacks crucial staff or 
equipment, to ensure surge capacity, or for other reasons).
One director had been advised by counsel that the absence of express legal authority prohibits 
the laboratory from entering into test service sharing agreements with other states. The director 
indicated that the public health department was exploring the potential for new legislation that 
would expressly authorize test service sharing. The two directors whose laboratories are part of 
state universities indicated that the universities have authority to approve interstate test service 
sharing agreements and have granted that approval to the laboratories.
One laboratory is authorized to enter into such agreements only for emergency preparedness and 
response purposes. Over time, its successive legal counsel have voiced different interpretations 
of what constitutes an emergency. An earlier opinion held that emergency specifically denotes a 
statewide state of emergency declared by the governor. As of mid-2013, however, the incumbent 
counsel interpreted the term more broadly to include any situation that prevents the public health 
laboratory from performing tests that are required to protect the public’s health (e.g., equipment 
failure, temporary loss of testing capability because of staff turnover, or a mandate to perform a 
new test that the laboratory is not equipped to perform). On that basis, this state has developed an 
MOU with another state laboratory for NBS testing.
All states have enacted essentially uniform legislation authorizing provision and receipt of 
interstate mutual aid related to emergencies that are declared by governors. These statutes 
followed Congressional approval of EMAC in 1996.3 States’ EMAC agreements encompass all 
emergency-related state agencies and programs.4 Policy Guide research identified one use of 
EMAC authority for public health test service sharing: the Iowa state public health laboratory’s 
performance of NBS tests for Louisiana for a year after Hurricane Katrina occurred in 2005.
More generally, the model federal EMAC statute includes a provision for “temporary suspension 
of any statutes or ordinances that restrict the implementation of EMAC-authorized mutual 
aid.” Declaring an EMAC emergency might enable a state to engage in test service sharing by 
suspending its standing prohibition. Even if that happened, the authority for test service sharing 
would be in effect only for the duration of the governor’s declaration of emergency.
4.2	 Payment	for	Shared	Test	Services
The interviewed laboratory directors reported that making and receiving payment for test 
services that one state public health laboratory performs for a counterpart in another state can 
result in some of the most serious legal questions related to test service sharing. The state laws 
that govern public health laboratories’ charges for test services are highly diverse. Some laws are 
interpreted as prohibiting such charges. Among the states that do allow charges, some specify 
3 P.L. 104-321, 110 Stat. 3877 (1996).
4 See, for example, the California EMAC statute: Cal. Code Sec. 3.7-179.
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a fixed amount, whereas others permit full cost recovery. Laws often exempt certain types of 
testing from charges (e.g., tests conducted for reportable diseases or for the state’s public health 
department).
States vary also in the disposition of revenues received from testing charges. Arizona law, for 
example, requires them to be deposited in the state treasury to support general state needs. In 
contrast, Texas law directs testing receipts to a fund that is designated to support the state’s 
public health services. Kansas, Minnesota, Ohio, and possibly other states direct testing 
payments to funds designated specifically to support their public health laboratories. These 
heterogeneous approaches have diverse implications as laboratory leaders explore the merits of 
test service sharing.
In more detail, directors reported the following legal parameters related to interstate exchange of 
funds for test services:
• The majority of laboratories have legal authority to make payment to and receive payment 
from other states’ public health laboratories, but the directors reported legal limits on their 
laboratories’ ability to retain and use payment revenues.
• Two laboratories lack authority to pay or receive payment from other states’ public health 
laboratories.
• Seven of the laboratories have authority to deposit test-related (and other) revenues 
in dedicated funds they control. The Florida state laboratory, for example, deposits 
the payments it receives from Louisiana for HIV-related testing in a fund established 
specifically for use by the Bureau of Public Health Laboratories.
• Multiple states require that such payments go to the state’s general fund or other funds 
that the laboratories do not control, preventing them from recouping their costs. In certain 
cases, only revenues that exceed a specified level must go to those funds.
• The state laboratories that perform NBS tests for other states use contracts that include 
agreed-upon fees they charge for the service. The testing laboratories have legal authority 
to charge such fees and to use the income to cover the testing costs. The contracts are 
executed with the NBS programs of the client states rather than with their state laboratories.
States’ EMAC statutes expressly authorize them to pay each other for mutual assistance, greatly 
facilitating test service sharing during governor-declared emergencies. (See Resource 4 for an 
example of that standard provision). In contrast, state laboratories have had to rely on informal 
arrangements with other states when their operations are interrupted by flooding, equipment 
failure, and other developments that do not warrant a governor’s declaration of emergency.
Related concerns that laboratory directors voiced include
• the difficulty some laboratories have in obtaining legislative or executive branch approval 
to charge fees that cover tests’ actual costs, which tend to increase over time; and
• the possibility that a laboratory that performs tests might be required to charge testing fees 
that the requesting laboratory cannot afford.
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APHL and CDC staff reported that the two following, potentially problematic, legal questions 
had surfaced, but were resolved, during planning for two CDC-sponsored test service sharing 
projects:
• Some of the laboratories that planned to submit specimens to VPD reference laboratories 
indicated that their state procurement laws would require them to solicit competitive bids 
from other public and private laboratories if the reference laboratories charged a fee for 
the testing. Inclusion of those laboratories might have detracted from the pilot-test design. 
In the final event, the fact that CDC provided funds to support the reference laboratories’ 
activities avoided that potential problem.
• In the HIV NAT Referral Project, the Florida state public health laboratory — one of the 
laboratories selected to perform NAT testing for the other participating laboratories — 
reportedly was prohibited by law from receiving payment from other states. This potential 
problem was averted by CDC’s financial support for the Florida laboratory’s activities, also 
extended through an APHL cooperative agreement.
One laboratory director stated that his laboratory would need to have third-party billing 
capability before it could participate in test service sharing and that new legislative authority 
would be required to bill insurance plans. The director was not optimistic that approval would 
be forthcoming and also noted that the likely volume of tests would be too low to justify costly 
investment in new billing capability.
4.3 Risk Management
State governments want to minimize their liability for acts of commission or omission by 
other parties, including acts by either of the state laboratories engaged in test service sharing. 
The directors reported that concerns about liability have ranked high among the challenges 
to developing test service sharing contracts between states. In this context, actions that 
might prompt claims include delayed or inaccurate reporting of test results, loss or misuse of 
specimens, and breaches of privacy.
Laboratories can address liability concerns as they negotiate formal test service sharing 
agreements, whether they use contracts or MOUs as vehicles. Negotiation can identify and 
allocate the responsibility for liability risks between the involved states. One option, for example, 
is to include an indemnification provision in which one or all parties agree to compensate the 
others for loss or damages they suffer. Such a provision can specify the indemnifying state’s 
liability and provide for recovery of fees and other costs incurred in exercising indemnification. 
The participating states also can choose, if they desire, to define the types of events that might 
trigger indemnification and the scope of actions to which indemnification applies.
Several state laboratory directors reported they had worked for extended periods to develop new 
test service sharing agreements only to be rebuffed when counsel for the involved states were 
unable to resolve liability concerns, including “choice of law” and jurisdiction (i.e., specification 
of the state whose laws will govern in the case of a dispute).
Directors often reported success in resolving liability questions through negotiation with their 
counsel and the partnering state laboratory. Instances include, for example, the 2013 Four 
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Corners MOU for surge testing during emergency situations and the Florida-Texas MOU for 
backup NBS testing. Both include mutual indemnification clauses that limit liability to the party 
deemed responsible for a specified act.
Laboratory directors also reported success in increasing their counsels’ understanding of the 
laboratories’ work. This included appreciation for the extensive quality-assurance measures 
that help protect the privacy and confidentiality of the persons associated with test specimens, 
accreditation requirements that help ensure compliance with federal guidelines, and other 
safeguards that reduce the likelihood of claims against the state.
4.4	 Privacy	Protection
Public health laboratories are subject to federal and state laws that protect individuals’ privacy 
and the confidentiality of information related to their health. However, laboratories that are part 
of public universities might be subject to additional protections adopted by those institutions. 
Research for this Policy Guide did not identify any substantial impediments to interstate test 
service sharing related to federal or state privacy and confidentiality laws and policies.
4.4.1 The Health Insurance Portability and Accountability Act and the Health 
Information Technology for Economic and Clinical Health Act 
The pertinent federal law is the Health Insurance Portability and Accountability Act (HIPAA) 
of 1996.5 HIPAA created national privacy and security safeguards for individually identifiable 
health information — protected health information — including standards for health information 
that is transmitted electronically. Protected health information comprises any health information 
that “identifies an individual or with respect to which there is a reasonable basis to believe the 
information can be used to identify the individual.” Congress revised and strengthened those 
protections in the 2009 Health Information Technology for Economic and Clinical Health 
(HITECH) Act.6 The U.S. Department of Health and Human Services issued a final rule to 
implement the 2009 provisions on January 25, 2013.7 
HIPAA establishes nationally uniform, minimal safeguards for individually identifiable 
information that typically applies to “covered entities” (e.g., health care providers, health plans, 
and health clearing houses). They also apply to those entities’ affiliated “business associates” 
(e.g., claims processors and data services). HIPAA permits disclosure of such information to 
“public health authorities” and allows them to use and disclose it “consistent with the laws, 
regulations, and policies applicable to [that] public health authority.”8 
5 P.L. 104-191. 110 Stat. 1936 (codified as amended in sections of Titles 18, 26, 29, and 42 of the U.S. Code).
6 Title XIII of Division A and Title IV of Division B of the American Recovery and Reinvestment Act of 2009  
(ARRA), P.L. 111-5, 123 Stat. 226 (codified at 42 U.S.C. sections 300jj et. seq.; sections 17901 et. seq. 
7 See: Modifications to the HIPAA Privacy, Security, Enforcement, and Breach Notification Rules under the Health 
Information Technology for Economic and Clinical Health Act and the Genetic Information Nondiscrimination Act: 
Other Modification to the HIPAA Rules, 78 Fed. Reg. 17.5566-5702 (Jan. 25, 2013). To be codified at 45
8 Hodge, J. The HIPAA Privacy Rule and Public Health Laboratories: Guidance prepared for the Association of 
Public Health Laboratories. Not dated. Available at: http://www.schs.state.nc.us/hipaa/references/APHL_HIPAA_
Guide1-for-Public-Health-Labs.pdf.
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A public health laboratory that performs tests or other services related to the provision of health 
services to an individual — in addition to tests for public health purposes — might be considered 
a covered entity or a hybrid entity and thus be required to comply with HIPAA. The New 
Mexico public health laboratory, for example, is located within the state department of health, 
which is a covered entity. At least two more of the 17 state public health laboratories appear to 
be hybrid entities (i.e., performing both covered and noncovered functions). Covered entities 
wmust have agreements in place with business associates to ensure that they too comply with the 
HIPAA protections. One of the effects of the HITECH Act was to strengthen the requirements of 
business associates, including making them directly liable for compliance.9 
HIPAA privacy and security requirements have had implications for at least one of the existing 
test service sharing arrangements initiated by the 17 states: the Four Corners MOU among 
Arizona, Colorado, New Mexico, and Utah. The New Mexico laboratory is a covered entity 
and thus must comply with the HITECH Act requirements. The three other state laboratories 
are considered business associates of the New Mexico laboratory, and New Mexico requested 
they sign those new agreements. Ultimately, the confidentiality agreements those states require 
their employees to sign were determined to be sufficient for the purpose, and the new MOU was 
finalized in 2013.
As reported by the 17 laboratory directors and their colleagues, the HIPAA requirements appear 
to have had no other implications for interstate test service sharing.
4.4.2	 State	Privacy	Laws
All states have adopted legal protections for health information that supplement and, in certain 
cases, go well beyond the HIPAA protections. States may not adopt protections that are weaker 
than or conflict with the HIPAA protections.
Public health laboratory directors, staff, and counsel interviewed by the Policy Guide researchers 
reported instances in which state privacy-related laws and policies have surfaced related to test 
service sharing.
• One laboratory reported that its state public records law prohibits disclosure of an 
individual’s health information except when the person consents, during a medical 
emergency, pursuant to a court order, or for specified health research purposes. This 
provision affected implementation of an emergency-related agreement with another state 
because it prohibited use of identifiable patient information during a joint emergency 
exercise.
• The Florida-Texas MOU supports NBS testing in the event of an emergency. As part 
of developing that agreement, Texas was required to confirm it would comply with the 
provisions of Florida’s open records law regarding protection of patient-identifiable 
information from public disclosure.
• Public health agencies and other entities often enter into data-use agreements to define 
parties’ rights to use data that others have developed and to specify parties’ responsibility 
for privacy and confidentiality. During Policy Guide research, at least one state public 
9 42 U.S.C. section 17931.
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health laboratory director indicated he planned to require other state laboratories to sign 
data-use agreements before sharing tests and test results.
• One point that surfaced as the Four Corners MOU was updated in 2013 was whether 
unlawful use or disclosure of a patient’s protected health information should be reported 
by the testing laboratory to all three of the other members. The conclusion reached was 
that such events would be reported to all three but that individually identifiable information 
should be reported only to the requesting state laboratory.
4.5	 Certification	and	Licensure
Public health laboratories operate under externally imposed systems designed to ensure they 
meet specified quality standards. Some of these systems are based in federal or state law and 
are administered by government agencies. Others have been designed by independent, scientific 
bodies. The systems also vary according to the types of tests that a given laboratory performs. 
The concerns discussed in this section relate mainly to the predominant focus the Policy Guide 
has on testing that involves human specimens. Laboratory directors interested in exploring 
test service sharing might want to review certification and licensure information relevant to 
environmental and other types of testing that do not involve human specimens.
4.5.1	 Clinical	Laboratory	Improvements	Amendments
The federal Clinical Laboratory Improvement Amendments (CLIA) of 1988 require all private 
and public laboratories in the United States that test human specimens for health assessment or 
to diagnose, prevent, or treat disease be inspected and certified by the Centers for Medicare and 
Medicaid Services (CMS). Exceptions are laboratories in New York State and Washington State 
whose state-mandated inspection and certification requirements CMS deems equivalent to those 
of CLIA. Certain private and public laboratories also are accredited by such organizations as the 
nonprofit College of American Pathologists.
All state public health laboratories are CLIA-certified or are accredited by other programs 
authorized by CMS for that purpose. The majority of the laboratory directors interviewed during 
Policy Guide research agreed that another laboratory’s CLIA certification is sufficient evidence 
of its quality practices to qualify it legally to perform tests on behalf of their own laboratories.
CLIA requires that the name of the laboratory that performs a test be documented in the test 
results. The interviewed laboratory directors noted that tests one state’s public health laboratory 
conducts for another state’s laboratory must include that information. This reportedly is done 
routinely. One laboratory includes such a requirement in its test service sharing agreements.
CLIA, in sum, does not appear to pose any substantial impediments to test service sharing. In 
fact, CLIA’s requirements for maintaining testing proficiency might be an impetus to sharing. 
Interviewed laboratory directors often indicated that maintaining testing proficiency for low-
volume tests can be expensive and time-consuming, which encourages state laboratories to 
consider having other states perform those tests for them.
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4.5.2 State Laboratory Accreditation
New York state law requires that all laboratories that conduct diagnostic tests on human 
specimens collected in New York be certified by the state’s Clinical Laboratory Evaluation 
Program (CLEP). Although some out-of-state commercial and hospital laboratories are CLEP-
certified, no other states’ public health laboratories are. CLEP certification entails considerable 
work and time. Further, even after certification, New York State must approve each test method 
as well. These burdens are among the reasons that no other state’s public health laboratory has 
been CLEP-certified, and thus, this statutory mandate is a barrier to the New York public health 
laboratory’s participating as a requesting state in test service sharing. To perform tests for New 
York State, an out-of-state public health laboratory must be CLEP-certified, even if New York 
needs its assistance in responding to emergencies.
Even though Washington State, like New York State, operates its own CLIA-like certification 
program, its public health laboratory is legally allowed to have other states’ public health 
laboratories perform tests on its behalf as long as they are certified by CLIA. The Washington 
laboratory participates actively in test service sharing.
4.5.3 State Personnel Requirements
In addition to the CLIA personnel requirements, 12 states and Puerto Rico have established their 
own laboratory personnel licensure requirements (the states are California, Florida, Georgia, 
Hawaii, Louisiana, Montana, Nevada, New York, North Dakota, Rhode Island, Tennessee, and 
West Virginia).
Some states that have such standards require out-of-state laboratories to comply with them 
when sharing specimens with in-state laboratories, whereas others provide an exemption to 
the additional requirements for CLIA-certified laboratories. The responsibility rests with the 
submitting laboratory to ensure testing personnel have the necessary licenses for those states.
4.6 Specimen Management and Use
Participating laboratory directors were asked whether, in their experience, legal factors related to 
use and management of test specimens had posed substantial impediments to test service sharing. 
No concerns were identified, whether related to shipping, use in tests, or disposition of samples 
after testing.
Public health laboratories’ use of specimens they receive from other states is governed mainly 
by the laboratories’ standard operating practices. The Four Corners MOU, as one example, 
does not include mention of specimen-related concerns. Interviewed laboratory directors noted 
that controversies in recent years have centered on practices related to NBS testing samples — 
for example, their use in biomedical research — but reported that they have not experienced 
negative consequences regarding test service sharing.
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One laboratory director, whose state was involved in a specimen-related controversy, described 
the data-use agreement it developed with another state as they shaped an NBS test service 
sharing MOU to provide surge capacity during emergency situations. This director observed 
that the laboratory’s legal counsel favors adopting formal policies for key elements of the 
NBS testing process; however, that step had not been taken as of mid-2013, and whether any 
implications would result for that state’s participation in NBS test service sharing is unclear.
A different question this state laboratory and its partner laboratory addressed as they developed 
the MOU was how to align their different, legislatively mandated test panels. This prerequisite 
to execution of the MOU was resolved through technical discussions during months-long 
negotiations.
4.7 Disease Reporting
The participating public health laboratory directors did not report encountering problems 
stemming from states’ disease reporting requirements. Nonetheless, the potential for such 
problems was recognized. Such requirements often apply to public health laboratories and can 
entail responsibilities with which a given laboratory is unfamiliar or, conceivably, unprepared or 
unauthorized to fulfill.
All 17 participating states require laboratories to report selected communicable diseases. The 
states’ laws vary in terms of who is required to report, the diseases that are reportable, to whom 
reports must be made, reporting time frames, report content, reporting methods, and other points. 
State laboratories that are considering entering into a test service sharing agreement might want 
to review such requirements and assess their implications. 
Some states have disease-reporting laws that specifically address out-of-state laboratory testing 
and that might have implications for test service sharing by public health laboratories. For 
example,
• Florida requires out-of-state laboratories that collect or receive Florida specimens to report 
results by using the same procedures as do in-state laboratories.10
• Connecticut requires out-of-state laboratories that conduct examinations on specimens 
that have been referred from Connecticut to submit reports in the same manner as in-state 
laboratories, along with “a clear statement that such findings were obtained in [the out-of-
state] laboratory” and including the name and location.11
• Both California and Wisconsin stated that, when an out-of-state laboratory obtains a 
positive result for (a reportable disease or condition, as defined in their laws) and reports 
its finding to an in-state laboratory, the California or Wisconsin laboratory is responsible 
for notifying the appropriate California and Wisconsin health authorities as if their own 
laboratories had performed the tests.12
• Iowa requires out-of-state laboratories to report any confirmed or suspected case of a 
reportable disease or condition in an Iowa resident to its department of health.13
10 Fla. Admin. Code R. 64D-3.031.
11 Regs. Conn. State Agencies section 19a-36-D32.
12 See: 17 Cal. Code Regs. Section 2505, and Wis. Admin, Code DHS section 145.09.
13 Iowa Admin. Code 641-1.4.
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4.8 Emergency Management
Laboratory directors did not cite emergency management laws as having posed problems for 
test service sharing. As noted previously, two state public health laboratories used their EMAC 
statutes as authority for sharing test services.
At the same time, the possibility exists that state or federal emergency management laws might 
complicate test service sharing agreements, and laboratory directors might want to consider 
that possibility as they explore developing such agreements. This section gives an overview of 
selected pertinent laws and reviews their potential implications for developing and implementing 
formal test service sharing agreements.
4.8.1	 General	State	Emergency	Management	Laws
All states have enacted laws that authorize preparation for and execution of actions related to 
public health and other types of emergencies. Although these laws vary in key ways from state to 
state, the majority have important common elements.
•	 Definition	of	Emergency — In this context, state laws typically define an emergency 
as a catastrophic event that affects a wide area and causes severe injury, loss of life, or 
property damage. Natural disasters are examples. Some states further define public health 
emergencies as including the occurrence of a disease or appearance of an infectious agent 
that poses substantial risk for death or disability to a considerable number of persons. States 
also sometimes specify intentionally caused biologic, chemical, and radiologic threats as 
public health emergencies.14 
•	 Interstate Emergency Assistance — Certain states have entered into mutual aid 
agreements that authorize them to provide assistance to each other to mitigate the effects of 
public health and other types of emergencies.
•	 Planning	for	and	Responding	to	Actual	Emergencies	— Different aspects of states’ 
emergency management laws might have implications for state public health laboratories’ 
participation in test service sharing during planning for and response to actual emergencies. 
For example, some states empower their governors to execute emergency-related mutual 
aid agreements; some states condition that authority on approval by their legislature. Other 
states allow the adjutant general or even the directors of local emergency management 
agencies to enter into mutual aid agreements, subject to approval by the governor.
•	 Services Provided — The scope of mutual aid services that can be provided varies across 
states’ laws. Some authorize broad services; others are narrow. Some but not all states also 
have passed laws and developed interstate agreements that specifically authorize provision 
of services related to public health laboratories’ operations.
14 See, for example, section 104 of the Model State Emergency Health Powers Act. The Center for Law and the 
Public’s Health at Georgetown and Johns Hopkins Universities. Available at: http://www.publichealthlaw.net/
ModelLaws/MSEHPA.php.
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4.8.2 EMAC Legislation
All states, the District of Columbia, Puerto Rico, Guam, and the U.S. Virgin Islands have enacted 
uniform EMAC legislation to authorize provision of a broad spectrum of services to each other. 
An important precondition is that assistance can be provided under EMAC authority only if the 
governor of the affected state officially declares that an emergency exists. 
EMAC provisions facilitate test service sharing during declared emergencies, but the same 
provisions conceivably might address legal questions that complicate test service sharing outside 
of emergencies.
•	 Liability — States’ EMAC statutes address liability directly. They specify that “officers or 
employees of a party state rendering aid in another state” are covered by the tort liability 
and immunity provisions of the requesting state. This clause provides uniform protection 
to the assisting states. Its inclusion in all the states’ EMAC statutes reflected recognition 
that liability questions, if left unresolved, would pose serious complications for effective 
response and that a common solution was needed. Although the EMAC liability clause 
appears to address the question adequately for state public health laboratories’ purposes 
in the context of declared emergencies, no similar solution appears to be available during 
nonemergent settings.
•	 Reimbursement	— The EMAC statutes provide for reimbursement of the costs an 
assisting state incurs. That state “shall be reimbursed by the [requesting] state for any loss 
or damage to or expense incurred in the operation of any equipment and the provision of 
any services in answering a request for aid and for the costs incurred in collection with 
such requests . . . .” This, however, is not a blanket mandate. Assisting states can opt to 
bear some of the costs. Further, the participating states can agree to “establish a different 
allocation of costs . . . .” These qualifications provide useful flexibility to the states.
•	 Licenses and Permits — The EMAC statutes are also helpful regarding legal questions 
outside of declared emergency situations through licensing and related requirements 
pertinent to public health laboratories. In essence, the Licenses and Permits clause of 
the EMAC statutes deems that “any person, who holds a license, certificate, or other 
permit issued by any state party” meets the counterpart requirements of a state requesting 
assistance. One exception to this reciprocity provision is that the governor of the 
requesting state can apply limits on such recognition “by executive order or otherwise.” 
The EMAC laws, however, appear not to address two points important to state public 
health laboratories’ participation in mutual aid. One is that a laboratory professional 
in the assisting state might not hold a license that a requesting state requires of its own 
laboratory professional. In such a case, the requesting state might not be able to deem that 
professional qualified to assist. Also, the EMAC statutes do not address facility licensing 
(i.e., laboratory licensing requirements). At least hypothetically, a state laboratory that 
proposes to provide assistance but is not licensed by the requesting state might not be able 
to do so legally, unless the governor of the requesting state invokes the exception noted 
previously.
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5. EXPLORING POLICY CONSIDERATIONS
This section presents selected considerations — based on the experiences of the 17 laboratories 
that participated in the Policy Guide research — that public health laboratory leaders and their 
counsel might find helpful as they explore the potential benefits and feasibility of sharing testing 
services with other state public health laboratories.
5.1	 Assessing	the	Potential	Value	of	Shared	Testing	Services
Assessing the potential value of sharing services is the starting point for exploring policies that 
are supportive of test service sharing. Questions that laboratory directors and their staff ask as 
part of these assessments often focus on potential cost savings in laboratory operations, quality 
and timeliness of test results, and the ability to maintain laboratory capacity in light of rapid 
changes in technology and the larger health care–public health system.
Specific examples of the types of factors that two state laboratories have considered appear in 
LEI’s Practical Guide to Assessing and Planning Implementation of Public Health Laboratory 
Service Changes.15  The following questions address some of these concerns:
• Is it cost-effective to perform low-volume, labor-intensive tests in-house?
• Can the investment be justified for acquiring and maintaining the new equipment?
• Is the expertise needed to perform new types of tests available in-house?
• If a laboratory is considering performing tests for another state’s laboratory, does it 
have the necessary staff proficiencies or can it acquire them at an affordable cost? (Both 
laboratories might need to ensure they retain the workforce needed for high-volume surge 
testing related to an extended public health emergency.)
• Can a laboratory that is considering having another laboratory perform tests on its behalf 
be confident that critically important tests will be conducted and reported correctly during 
emergencies and other high-visibility events?
5.2	 Assessing	Laws	and	Legal	Considerations
This Policy Guide is a resource that public health laboratory directors and their staff and counsel 
can use in exploring legal and other policy considerations that can be important factors in their 
decision whether and how to enter into test service sharing with other state laboratories.
 
5.2.1 Checklist
The checklist in Resource 1 outlines steps that public health laboratory directors might want to 
consider taking as they organize and conduct assessments of the laws and policies of their states 
that are relevant to formal agreements for test service sharing.
15 Available at: http://www.aphl.org/MRC/Documents/LEI_2012Nov_Public-Health-Laboratory-Service-Changes-
Practical-Guide.pdf.
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5.2.2 Self-Assessment Tool
The self-assessment tool in Resource 2 can be helpful when exploring policy concerns by posing 
questions related to the legal topics included in Section 4 of this Policy Guide. This tool is 
intended to be a beginning point. Laboratory directors and their colleagues will have additional 
questions and topics that reflect their particular goals and circumstances; they should modify the 
tool to suit their own purposes, as necessary.
Directors might use self-assessment results for different purposes, including, for example,
• pinpointing specific obstacles to test service sharing;
• bringing those problem areas to the attention of legal counsel, administrators, and others 
who might be able to help resolve them; and
• as a basis for exploring the benefits and feasibility of potential legislative or policy 
changes, if that is deemed necessary.
Directors might find that taking a team approach to using the self-assessment tool is most 
productive. Laboratory scientists and technicians, laboratory and program managers, health 
department policy staff and counsel, and managers in the health department and the state 
procurement agency all can bring valuable knowledge to bear.
5.2.3	 Exploring	Existing	Laws	and	Policies
The existing laws and policies that public health laboratories have identified as supportive of test 
service sharing are a valuable resource. Resource 3, available in full to APHL members in the 
APHL Members Resource Center, lists the contracts and MOUs that laboratory directors offered 
for inclusion in this Policy Guide, along with others identified by the Policy Guide researchers. 
These might be used as templates for development of new test service sharing agreements in 
other states.
Examples of the supportive provisions that are available in these resources include the following:
Payment for Shared Test Services
• Minnesota legislation, enacted in 2013 and effective in 2014, authorizes the infectious 
diseases laboratory to charge submitters for the full cost of performing tests, with 
exemptions for tests for mandated disease reporting. Earlier law had allowed only a 
handling fee of $25/test. The income will be deposited into a fund for use by the laboratory.
Liability
• A provision of the Four Corners MOU states that each participating laboratory assumes 
liability for its actions but does not waive the state’s sovereign immunity.
• The contract between the South Carolina and Alabama state public health laboratories 
includes a section that limits their liability to their own acts and omissions.
• A similar EMAC provision states, “No party state or its officers or employees rendering aid 
. . . shall be liable on account of any act or omission in good faith . . . . ”
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Privacy
• The privacy provisions of the Four Corners MOU that were crafted specifically to comply 
with HIPAA and HITECH Act requirements include a data-use agreement as an integral 
part.
• The open records provision of the MOU that the Florida and Texas laboratories developed 
for NBS test service sharing specifically addresses privacy concerns.
Resource 4 contains additional examples of such provisions.
Alternative Legal Vehicles
Assessing the potential that other existing or new state laws can have for facilitating test 
service sharing can be useful. One example is the laws that the vast majority, if not all, of 
states have enacted that give broad authority to their agencies to exchange services with the 
agencies of other states. These statutes have varying titles (e.g., “intergovernmental cooperation 
agreements,” “joint powers agreements,” and “interlocal cooperation acts”), many of which 
authorize interstate as well as intrastate service sharing. Legal analysis can determine if such 
broad authorities preclude the need to attain express permission to share testing services.
The following are two such examples:
• The New Mexico Joint Powers Agreements Act authorizes “two or more public agencies 
[to] jointly exercise any power common to the contracting parties, even though one or more 
of the contracting parties may be located outside this state, . . . ” subject to approval by the 
state secretary of finance and administration.
• The Minnesota Joint Exercise of Powers statute authorizes “any agency of the state” to 
enter into agreements with “another state,” among other types of entities, for cooperative 
activities and to make related payments. The law also speaks to liability concerns.
Laboratory directors also might want to explore potential adoption of new state legislation. 
Maryland passed legislation in 2011 that authorizes its state and local public health laboratories 
to enter into mutual aid agreements with counterparts in other states, provide assistance to them, 
and receive assistance from them. The legislation follows EMAC provisions. Among other 
points, it provides for mutual indemnification and for expenditures to be charged to Maryland 
funding sources. (Other Mid-Atlantic states pursued parallel legislation but were unsuccessful. 
Consequently, the Maryland statute was inactive at the time this Policy Guide was prepared.)
5.2.4 Bibliography
Resource 5 lists selected reports, analyses and other publications relevant to test service sharing 
that can be helpful as laboratory directors and their colleagues explore legal and other policy 
considerations.
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5.3	 Working	with	Current	and	New	Partners
The laboratory directors who contributed to this Policy Guide underscored the importance 
of communicating effectively with key partners in exploring policy options for interstate test 
service sharing.
5.3.1 Current Partners
Public health laboratories’ established partners and stakeholders typically include, at a minimum, 
state health officials, state epidemiologists, leaders of the health agencies’ programs that rely on 
test results and other laboratory services, legal counsel, state procurement officials, and senior 
decision makers in the laboratory’s parent organization. Elected policymakers also might be key 
stakeholders.
The participating laboratory directors pointed to barriers that diverse professional cultures can 
pose. Legal counsel and procurement officials, for example, are expected to ensure adherence 
to rules that are broadly applicable to state government agencies. They might not be aware 
that those rules have unintended and problematic consequences for laboratories’ effectiveness. 
Communicating with these partners before an emergency occurs can help them better understand 
the crucial role the laboratory plays in protecting health, the need to maximize the laboratory’s 
effectiveness, and the potential benefits of participating in test service sharing arrangements with 
other jurisdictions.
At a more granular level, laboratory directors made concrete recommendations for improving the 
development process for new MOUs and contracts with other states by —
• using clauses and provisions that the involved states have accepted in earlier negotiations. 
One source of frustration when developing a new test service sharing agreement is for one 
of the states to propose provisions that had been rejected during negotiations over an earlier 
agreement. A more productive and time-saving approach, the directors recommended, is for 
both parties to agree to use already approved language as the basis for a new agreement.
• using provisions that other states have identified as supportive of their test service sharing 
goals and that their counsel, procurement officials, and other administrative officers have 
endorsed. Examples of such provisions appear in Resource 4.
5.3.2	 Potential	New	Partners
Laboratory directors reported that exploring collaboration with new types of partners can be 
fruitful. Three examples of such potential partners follow:
Public Institutions of Higher Education
• The directors of public health laboratories that are part of their states’ public universities 
reported that they typically have greater flexibility in establishing formal agreements with 
counterparts in other states and in making and receiving payment for shared test services. 
Directors of laboratories that are part of state agencies might find exploring opportunities to 
partner with institutions of higher education productive.
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Nonprofit Public Health Institutes
• Established in 1953, the nonprofit Health Research, Inc. (HRI) is chartered to assist the 
New York State health department “to effectively evaluate, solicit, and administer external 
financial support for DOH . . . projects, and to disseminate the benefits of scientific 
expertise through programs such as technology transfer.” Among other activities, HRI may 
apply for federal and other grants on behalf of the New York public health laboratory, make 
purchases on the laboratory’s behalf, and hire staff for specified projects.
• Approximately 30 states are served by nonprofit public health institutes. Some are free-
standing nonprofit organizations themselves, whereas others are affiliated with public 
universities. (A directory to public health institutes is available from the National Network 
of Public Health Institutes at http://www.nnphi.org/.)
Philanthropic Foundations
• Many states and metropolitan areas are served by philanthropic foundations dedicated to 
improving health and the health system, of which public health laboratories are a vital part. 
Examples include the Kansas Health Foundation and The Health Foundation of Greater 
Cincinnati.
• During the 1980s and 1990s, a considerable number of health care insurers (e.g., Blue 
Cross Blue Shield plans) . . . converted from nonprofit to for-profit status.” These 
“conversion foundations” often have mandatory public service responsibilities and thus 
experience collaborating with state and local public health agencies. In its 2009 report, A 
Profile	of	Foundations	Created	from	Health	Care	Foundations, Grant Makers in Health 
identified 1,997 US conversion foundations.16
Laboratory directors’ dialogue with leaders of these nonprofit organizations revealed ways in 
which they can support test service sharing (e.g., by acting as partners of the laboratory’s parent 
health agency, similar to New York’s HRI) or in other capacities.
 
16 Available at: http://www.gih.org/usr_doc/2009_Conversion_Report.pdf.
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Resource	1:		Checklist	for	Assessment	of	Test	Service	Sharing	Laws	and	Legal		
Considerations
This checklist is offered as a broad outline of steps state public health laboratory directors might consider 
taking as they explore legal and policy concerns relevant to shaping formal agreements for interstate test 
service sharing. The checklist is intended to be flexible and adaptable to the specific goals and interests of 
any given public health laboratory. Directors should modify it and take other approaches as needed.
The checklist reflects elements of the assessment framework in the Practical Guide to Assessing and 
Planning Implementation of Public Health Laboratory Service Changes that the Association of Public 
Health Laboratories and the Centers for Disease Control and Prevention published in May 2012 as part 
of the Laboratory Efficiencies Initiative. The user should refer to the Practical Guide for additional 
information (available at: http://www.aphl.org/MRC/Documents/LEI_2012May_PHL-Service-Changes-
Guide.pdf). The checklist is organized into three parts, in a general chronological manner —
• Planning for a legal assessment
• Implementing a legal assessment
• Synthesizing and applying findings
Step Notes
A. Planning for a legal assessment
1.	 Deciding	whether	to	conduct	a	multistate	assessment
•	 Weighing	the	advantages	of	conducting	a	legal	assessment	in	
collaboration	with	another	state’s	public	health	laboratory	versus	
completing	one’s	own	state	assessment	first
2.	 Deciding	whom	to	involve	in	the	assessment	process,	for	example,
•	 The	laboratory	director,	senior	managers,	and	policy	advisers
•	 Legal	counsel	to	the	laboratory
•	 Health	department	leadership
•	 The	state	epidemiologist
•	 Leaders	of	health	department	programs
3.	 Establishing	goals	for	the	assessment
•	 Reviewing	the	goals	for	engaging	in	test	service	sharing
•	 Reviewing	the	scope	of	test	service	sharing	—	that	is,	which	testing	
services	to	be	shared
4.	 Developing	the	assessment	plan
•	 Identifying	the	assessment	deliverables
•	 Developing	a	work	plan	and	timeline
•	 Setting	out	participants’	roles	and	responsibilities
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Step Notes
B. Implementing a legal assessment
1.	 Deciding	on	a	framework	for	the	assessment
•	 The	Self-Assessment	Tool	that	appears	in	Resource	2	of	this	Policy 
Guide,	with	any	modifications,	or
•	 Another	tool	or	template	the	assessment	team	identifies	that	better	
reflects	the	priorities	and	goals	of	its	state
2.	 Determining	priority	considerations
•	 Identifying	laws	and	legal	considerations	that	experience	has	
proven	to	be	problematic	for	test	service	sharing
•	 Communicating	with	other	states’	public	health	laboratory	leaders	
to	identify	laws	they	have	identified	as	supportive	of	test	service	
sharing
3.	 Conducting	the	assessment
•	 Assigning	subject-matter–expert	participants	to	priority	concerns
•	 Assisting	their	assessments
—	 Existing	laws
—	 Alternative	legal	vehicles
—	 Working	with	current	and	new	partners
•	 Monitoring	preliminary	findings	and	shaping	assessment	efforts	as	
needed
C.	 Synthesizing	and	applying	findings
1.	 Reviewing	assessment	findings
•	 Assessing	the	quality	and	completeness	of	the	assessments
•	 Identifying	the	laws	and	related	practices	that	appear	to	have	the	
most	promise	for	supporting	test	service	sharing
•	 Identifying	those	that	appear	to	pose	problems	for	test	service	
sharing	
2.	 Integrating	the	findings	of	parallel	assessments	performed	by	a	
partnering	state	laboratory	or	laboratories
•	 Identifying	findings	from	parallel	assessments	that	indicate	the	
greatest	opportunity	for	development	of	supportive	laws	and	legal	
practices
3.	 Developing	plans	to	apply	assessment	findings
•	 Communicating	with	health	department	stakeholders	about	plans
•	 Communicating	with	external	stakeholders	(e.g.,	other	state	
agencies	and	health	care	partners)
•	 Communicating	with	policymakers
•	 Developing	consensus	among	stakeholders	on	optimal	action	plans
•	 Implementing	those	plans
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Resource	2:		Self-Assessment	of	Laws	and	Policies	Pertinent	to	Interstate	Test	
Service	Sharing
Test Service Sharing Function Assessment Comment
1. Performance of tests for another state’s public health laboratory (PHL)
a.	 Does	our	PHL	have	authority	to	perform	tests	for	
another	state	PHL?
b.	 Does	our	PHL	have	authority	for	another	state’s	PHL	to	
perform	tests	for	us?
c.	 Are	formal	agreements	(e.g.,	memoranda	of	
understanding	or	contracts)	in	place	to	implement	test	
service	sharing?
2.	 Payment	and	revenues
a.	 Do	our	state’s	laws	and	policies	authorize	our	PHL	to	
charge	another	state’s	PHL	or	its	programs	for	tests	we	
perform	for	them?
b.	 Do	our	state	laws	and	policies	authorize	our	PHL	to	
charge	health	insurance	plans	and	other	third	parties	for	
tests?
c.	 Do	our	state	laws	and	policies	authorize	our	PHL	to	set	
fees	and	charges?
d.	 Do	the	laws	and	policies	of	our	state	authorize	our	PHL	
to	retain	revenues	it	receives	from	another	state’s	PHL?
3. Risk management
a.	 Do	the	liability,	indemnification,	and	other	laws	and	
policies	of	our	state	support	our	PHL’s	performance	of	
tests	for	another	state’s	PHL?
b.	 Do	the	liability,	indemnification,	and	other	laws	and	
policies	of	our	state	support	having	another	state’s	PHL	
perform	tests	for	our	PHL?
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Test Service Sharing Function Assessment Comment
4.	 Privacy	and	exchange	of	information
a.	 Are	policies	in	place	to	ensure	protection	of	privacy	and	
confidentiality	related	to	shared	tests?	
b.	 Does	our	PHL	have	authority	to	exchange	information	
related	to	tests	and	test	results	with	another	state’s	
PHL?
c.	 Does	our	PHL	have	authority	to	exchange	information	
with	health	care	providers,	health	information	
exchanges,	and	other	entities?
5.	 Certification	and	licensure
a.	 Do	the	certification	and	licensure	laws	and	policies	of	
our	state	support	our	PHL’s	performance	of	tests	for	
other	state?
b.	 Do	the	certification	and	licensure	laws	and	policies	of	
our	state	support	another	state’s	performance	of	tests	
for	our	PHL?
6. Management of specimens
a.	 Do	our	state	laws	and	policies	enable	our	PHL	to	send	
specimens	to	and	receive	specimens	from	another	
state’s	PHL?
b.	 Do	the	laws	and	policies	of	our	state	and	of	other	states	
provide	for	safe	management	and	final	disposition	of	
specimens	used	in	shared	testing?
c.	 Do	the	laws	and	policies	of	our	state	and	other	states	
provide	for	the	research	use	(or	other	secondary	uses)	
of	specimens	that	are	used	in	shared	testing?
7. Test result reporting
a.	 Do	the	laws	and	policies	of	our	state	and	of	potential	
test	service	sharing	states	enable	timely	reporting	of	test	
results	to	support	the	surveillance	and	other	program	
needs	of	the	state	that	requests	testing?
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Resource	3:	Selected	Test	Service	Sharing	Agreements
Copies of the following memoranda of understanding (MOUs) and contracts — adopted by public health 
laboratories that participated in the Policy Guide research — are available to Association of Public Health 
Laboratories members in the Members Resource Center at http://www.aphl.org/Pages/default.aspx.
1. “Contract Between South Carolina Department of Health and Environmental Control, Bureau 
of Laboratories, and Alabama Department of Public Health,” 2011 — For tests for primary drug 
susceptibilities for Mycobacterium tuberculosis complex. 
2. “Memorandum of Understanding: Florida Bureau of Public Health Laboratories and [insert National 
HIV Behavioral Surveillance participant name],” undated — For confirmatory tests for preliminary 
positive point-of-care human immunodeficiency virus rapid test results.
3. “Memorandum of Agreement by and Between State of New Mexico Department of Health Scientific 
Laboratory Division, State of Colorado Public Health Laboratory, State of Utah Public Health 
Laboratory, State of Arizona Public Health Laboratory” (the “Four Corners MOU”), 2013 — For 
laboratory continuity of operations.
4. “Memorandum of Understanding Between Alaska Department of Health and Social Services, Public 
Health Laboratory, Idaho Department of Health and Welfare, Public Health Laboratory, Oregon 
Department of Human Services, Public Health Laboratory, Washington State Department of Health 
Public Health Laboratory” (the “Cooperative of State Labs”), 2004 — For testing, training, and 
identification of infectious diseases or suspected bioterrorism select agents.
5. “Pacific Northwest Emergency Management Arrangement Between The Government of the State 
of Alaska, The Government of The State of Idaho, The Government of The State of Oregon, The 
Government of the State of Washington, The Government of The Province of British Columbia, 
and The Government of The Yukon Territory” (“PNEMA”), circa 1996 — For coordination of 
emergency preparedness, response, and recovery. Annex B, 2005.
 Also: “Memorandum to Provide Mutual Aid through Sharing Public Health Laboratory Services, 
Washington State Department of Health and the Ministry of Health Services, British Columbia,” 
2010 — To “further the goals of [PNEMA] during an outbreak of disease, foodborne contamination, 
or suspected bio or chemical terrorism . . . that requires the expertise or capacity of the other Party’s 
laboratories.”
6. “Memorandum of Understanding — Laboratory Support Between the Mississippi Public Health 
Laboratory and the Bureau of Clinical Laboratories, Alabama Department of Public Health,” 2004–
2005 — For assistance in a severe disruption of analytical services or an emergency situation.
7. “Memorandum of Understanding — Laboratory Support Between the Tennessee Public Health 
Laboratory, Tennessee Department of Health, and the Bureau of Clinical Laboratories, Alabama 
Department of Public Health,” 2009 — For assistance during a severe disruption of analytical 
services or an emergency situation.
8. “Memorandum of Understanding Between State of Washington, Washington State Department of 
Health, Division of Public Health Laboratories, and State of California, California Department of 
Health Services,” 2005 — For Level 1 chemical agent analysis.
48	 Policy	Guide
Resources
9. “Partnership Agreement Between the Idaho Bureau of Laboratories and the Alaska State 
Environmental Health Laboratory,” 2011 — To cooperate and share laboratory services, procedures, 
responsibilities, and reimbursement for laboratory testing, training and identification of drinking 
water contaminants as listed in the Safe Drinking Water Act.
10. “Memorandum of Understanding Among Montana DPHHS Public Health Laboratory (MTPHL) and 
Idaho Public Health Laboratory (IDPHL),” 2010 — To perform viral testing as a result of a naturally 
occurring or intentionally caused disaster.
11. “Memorandum of Understanding Among Montana DPHHS Public Health Laboratory (MTPHL) 
North Dakota Public Health Laboratory (NDPHL),” 2011 — To perform routine molecular testing 
(influenza A and B, norovirus, pertussis, herpes simplex virus, varicella zoster virus, or Enterovirus) 
caused by a naturally occurring or intentionally caused disaster.
12. Contract between the New Hampshire Department of Health and Human Services and the University 
of Massachusetts, 2009 — For newborn screening testing.
13. “Memorandum of Agreement Between The Florida Department of Health, Newborn Screening 
Program, and The Texas Department of State Health Services, Newborn Screening Program,” 2013 
— For newborn screening during disasters or catastrophic technology failures.
14. Purchase of service agreement/contract between the North Dakota Department of Health and The 
University of Iowa, 2013 — For newborn screening testing.
15. State of South Dakota consultant contract/letter of agreement for consultant services between The 
University of Iowa and the South Dakota Department of Health, 2012 — For newborn screening 
testing.
Also available in the APHL Member Resource Center:
 
16. “Memorandum of Agreement Cooperative Services Agreement During Emergency Situations 
Between [State A Public Health Laboratory] and [State B Public Health Laboratory],” undated — 
For variola virus testing.
17. Legislation that Maryland enacted in 2007 to authorize Maryland public health laboratories to share 
testing services with public health laboratories in other states “to alleviate an emergency at one of 
the Maryland laboratories.” Maryland Health-General Code Ann. Sec. 17-104.
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Resource	4:	Selected	Provisions	of	Service	Sharing	Agreements
This resource presents selected provisions of state laws that have been adopted in formal public 
health laboratory test service sharing agreements (e.g., memoranda of understanding [MOUs] or 
contracts). They include provisions identified during Policy Guide research and others identified 
by the Association of Public Health Laboratories and the Centers for Disease Control and 
Prevention staff. The majority of these provisions were designed by state public health laboratory 
leaders to facilitate test service sharing in the context of their own laboratories’ roles and plans. 
They are offered here as examples that other public health laboratory directors might find 
helpful as they explore test service sharing arrangements to address their own unique goals and 
concerns. These provisions are not necessarily recommended for adoption by other states.
A.	 Authority	to	Participate	in	Test	Service	Sharing
 Express Authority for Test Service Sharing
• Maryland (Md. Code Ann., Health-Gen. section 17-104 (West 2008)
 “A public health laboratory in the state may enter into or renew a mutual aid 
agreement with a public health laboratory operated by another state.”
 “Mutual aid agreement means a written agreement . . . to assist each other in  
providing temporary testing services to alleviate an emergency at one of the 
laboratories.”
 Authority for General Emergency Mutual Aid
• California Emergency Management Assistance Compact (Cal. Code Sec. 3.7-179)
 “The purpose of this compact is to provide for mutual assistance between the states 
entering into this compact in managing any emergency or disaster that is duly 
declared by the governor of the affected state, whether arising from natural disaster, 
technological hazard, man-made disaster, civil emergency aspects of resource 
shortages, community disorders, insurgency, or enemy attack.”
 Joint Powers Agreements
• Minnesota (Minn. Stat. Sec. 471.59)
 “Two or more governmental units . . . may jointly or cooperatively exercise any 
power common to the contracting parties . . . . The term ‘governmental unit’ as used 
in this section includes every city, county . . . other political subdivision of this or 
another state, another state, . . .  and any agency of the state of Minnesota . . . .”
• New Mexico (N.M. Stat. Ann. section 11-1-3 (West 1978)
 “[T]wo or more public agencies [may] jointly exercise any power common to the 
contracting parties, even though one or more of the contracting parties may be located 
outside this state . . . .”
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B.	 Payment	for	Shared	Test	Services
• Model Emergency Management Assistance Compact (EMAC) state legislation 
enacted by Congress (P.L. 104-321, 110 Stat. 3877)
 “Any party state rendering aid in another state pursuant to this compact shall be 
reimbursed by the party state receiving such aid for any loss or damage or expense 
incurred . . . in connection with such requests; provided, that any aiding party state 
may assume in whole or in part such loss . . . and provided further, that any two or 
more party states may enter into supplementary agreements establishing a different 
allocation of costs . . . .”
• “Cooperative of State Labs” MOU, Attachment A, 2004 (See Resource 3)
 “This MOU is a non-financial agreement . . . and no billing for services will occur . 
. . . The Requestor will replace Testing Lab’s supplies with like supplies as soon as 
possible . . . . The Testing Lab may waive replacement of expenditures for supplies.”
• Minnesota 2013 legislation (Article 12 Health Dept. Sec. 13)
 “[T]he commissioner of health may enter into a contractual agreement to recover 
costs incurred for analysis of diagnostic purposes for each specimen submitted to the 
Department of Health by any hospital, laboratory, clinic, or physician . . . . Funds . . . 
shall be deposited in a special account and are appropriated to the commissioner for 
purposes of providing the services specified in the contracts.”
• State of South Dakota Consultant Contract, 2012 (See Resource 3)
 “Consultant agrees to . . . direct bill each submitting health care provider or birthing 
facility monthly, according to the fee schedule . . . attached hereto and incorporated 
herein.”
C. Risk Management
• Contract between South Carolina Department of Health and Environmental Control, 
Bureau of Laboratories, and Alabama Department of Public Health, 2011 (See 
Resource 3)
 “Neither party shall be liable for any claims, demands, expenses, liabilities, and losses 
(including reasonable attorney’s fees) which may arise out of any acts or failures to 
act by the other party, its employees or agents, in connection with the performance of 
services pursuant to this contract.”
• “Four Corners” MOU, 2005, renewed 2013 (See Resource 3)
 “Each party shall be solely responsible for fiscal or other sanctions occasioned as 
a result of its own violations or alleged violation of requirements applicable to the 
performance of the agreement. Each party shall be liable for its actions in accordance 
with this agreement, and federal and state law as applicable, including law of 
sovereign and governmental immunity. No term or terms of this MOA [memorandum 
of agreement] may be construed as an express or implied waiver of sovereign and 
governmental immunity.”
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• Florida and Louisiana MOU for newborn screening, 2013 (See Resource 3)
 “Each party to this agreement shall be responsible for its own acts and omissions 
and those of its officers, employees, and agents. No party to this agreement shall be 
responsible for the acts or omissions of entities not a party to this agreement. No 
party to this MOU agrees to release, hold harmless, or indemnify the other party from 
liability that may arise or relate to this MOU. Nothing herein is intended to serve as 
a waiver of sovereign immunity. Nothing herein shall be construed by any person or 
court as consent by a state agency or political subdivision of the State of [X] to be 
sued by third parties in any matter arising out of contract.”
• Model Emergency Management Assistance Compact state legislation enacted by 
Congress. (P.L. 104-321, 110 Stat. 3877)
 “Officers or employees of a party state rendering aid in another state pursuant to 
this compact shall be considered agents of the Requesting State for tort liability 
and immunity purposes; and no party state or its officers or employees rendering 
aid in another state pursuant to this compact shall be liable on account of any act or 
omission in good faith on the part of such forces while so engaged or on account 
of the maintenance or use of any equipment or supplies in connection therewith. 
Good faith in this article shall not include willful misconduct, gross negligence, or 
recklessness.”
• Purchase of Service Agreement/Contract, North Dakota Department of Health and 
The University of Iowa State Hygienic Lab, 2013 (See Resource 3)
 “Contractor agrees to defend, indemnify, and hold harmless the state of North Dakota, 
its agencies, officers and employees (State) from and against claims based on the 
vicarious liability of the State or its agents, but not against claims based on the State’s 
contributory negligence, comparative and/or contributory negligence or fault, sole 
negligence, or intentional misconduct.”
• Template MOU: Florida Bureau of Public Health Laboratories (See Resource 3)
 “Florida law, without giving effect to its choice of law principles, governs all matters 
arising under or related to the MOU. Venue for any legal actions arising herefrom is a 
state court of competent jurisdiction in Leon County, Florida.”
D.	 Privacy	Protection
• “Four Corners” Memorandum of Understanding, 2005, renewed 2013 
 “The parties agree to comply with the applicable provisions of the Administrative 
Simplification section of the Health Insurance Portability and Accountability Act 
of 1996 . . . as amended by Health Information Technology for Economic and 
Clinical Health Act of 2009 . . . and the requirements of any regulations promulgated 
hereunder including . . . [the ‘Federal Privacy Regulations’ and the ‘Federal Security 
Regulations’.] The parties agree not to use or further disclose any protected health 
information . . . or individually identifiable health information . . . concerning a 
patient other than as permitted by this Agreement and the requirements of HIPAA 
(See Resource 3)
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. . . . The parties shall implement appropriate safeguards to prevent the use or 
disclosure of a patient’s Protected Health Information other than as provided for by 
this Agreement. If a party that receives data pursuant to this Agreement becomes 
aware that a use or disclosure of such data was a use or disclosure of a patient’s 
Protected Health Information not provided for by this Agreement or in violation of 
HIPAA [Health Insurance Portability and Accountability Act], the Federal Privacy 
Regulations, or the Federal Security Regulations, the party will promptly notify each 
of the other parties of the use or disclosure . . . . In the event a party, with the approval 
of another party in writing, contracts with any contractors and/or agents to whom the 
party provides a patient’s Protected Health Information received from the party, that 
party shall include provisions in such agreements whereby the contractor and/or agent 
agree to the same restrictions and conditions that apply to that party . . . .”
• State of South Dakota Consultant Contract, 2012 (See Resource 3)
 “Consultant is a ‘hybrid entity’ as defined in the Health Insurance Portability and 
Accountability Act . . . and will abide by the rules and regulations set forth in 
[HIPAA] as amended by the Health Information Technology for Economic and 
Clinical Health (HITECH) Act . . . .”
• New Hampshire Department of Health and Human Services Contract with the 
University of Massachusetts for Newborn Screening Testing, 2009 (See Resource 3)
 “Business Associate [the University of Massachusetts] shall not use, disclose, 
maintain, or transmit Protected Health Information (PHI) except as reasonably 
necessary to provide the services outlined under Exhibit A of the Agreement.”
 “Business Associate shall require all of its business associates that receive, use, or 
have access to PHI under the Agreement, to agree in writing to adhere to the same 
restrictions and conditions on the use and disclosure of PHI contained herein . . . .”
E.	 Certification	and	Licensure
• Contract between South Carolina Department of Health and Environmental Control, 
Bureau of Laboratories, and Alabama Department of Public Health, 2011 (See 
Resource 3)
 “[E]ach party shall maintain its respective federal and state licenses, certifications, 
and accreditations required for the provision of services therein.”
• California Emergency Management Assistance Compact, 2005 (See Resource 3)
 “Whenever any person holds a license, certificate, or other permit issued by any 
state party to the compact . . . and when such assistance is requested by the receiving 
party state, such person shall be deemed licensed, certified, or permitted by the 
state requesting assistance to render aid involving such skill to meet a declared 
emergency of disaster, subject to such limitations and conditions as the governor of 
the requesting state may prescribe by executive order or otherwise.”
Policy	Guide											53
Resources
F. Specimen Management and Use
• “Cooperative of State Labs” MOU, Attachment A, 2004 (See Resource 3)
 “The Requestor is responsible for the . . . integrity of specimens [in shipping]. If the 
Testing Lab has safety standards for . . . transport of specimens within its borders, the 
Requestor shall incorporate [them] into its packaging and shipping processes.” “The 
Testing Lab will return positive samples to Requestor . . . as Requestor is responsible 
for integrity of specimens and chain of custody . . . .” “The Testing Lab will destroy 
negative samples according to its established procedures.”
G. Disease Reporting
• Florida (Fla. Admin. Code Ann. R. 64D-3.031)
 “(4) Laboratories located out of state, licensed under Part I, Chapter 483, F.S., 
who collect specimens in Florida or who receive the initial order for testing from 
a practitioner, blood bank, plasmapheresis center, or other health care provider 
located in Florida, shall report in the same way as if the findings had been made by a 
laboratory located in Florida.”
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